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NOTE
GIVE GRANDMA HER GANJA: EXPLORING THE
NEED FOR AN EXCEPTION TO THE
CONTROLLED SUBSTANCES ACT TO ALLOW
FOR MEDICAL MARIJUANA ADMINISTRATION
IN NURSING HOMES AND OTHER SKILLED
NURSING FACILITIES
I.

INTRODUCTION

At ninety-four years old, Joy Seligman is not feeling as joyous as
her name might imply. 1 Joy experiences "chronic pain from arthritis and
the debilitating tremors of Parkinson[']s" disease, which leaves her
dependent on Oxycodone for relief.2 Joy's home state of Florida
established a medical marijuana program in 2016.3 Seeking medical
marijuana as a less aggressive alternative to opioids, Joy went through
the "lengthy medical and paperwork process" necessary to become a
state-registered patient.4 However, after Joy presented her newly
obtained patient certification to her assisted living facility, "the facility
issued a new policy stating it 'does not support a client or resident's
right to use medical marijuana,' citing federal statutes that still consider
marijuana illegal."5 Unable to utilize medical marijuana to relieve her
symptoms, Joy remains suffering and dependent on narcotics for pain
relief. 6
Joy is not the only elderly patient residing in a nursing facility to be
denied access to medical marijuana, which is otherwise entitled under

1.

See Carrie Seidman, Siedman: Parkinsons Patient Denied Medical Marijuana at Sarasota

Assisted
Living
Center,
HERALD-TRiB.
(Feb.
20,
2018,
9:20
https://www.heraldtribune.com/news/20180219/seidman-parkinsons-patient-denied-medicalmarijuana-at-sarasota-assisted-living-center.
2. Id.
3. Id.
4. Id.
5. Id.
6. See id.

AM),

275
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state law.7 Though thirty-three states have now legalized medical
marijuana, 8 few nursing homes or assisted living facilities located in
9
these states permit their patients to utilize medical marijuana. Of those
facilities that do, some admit that they use loopholes and technicalities to
evade federal law.10 This is because marijuana is currently a banned
substance under the Federal Controlled Substances Act ("CSA") and as a
result, elder facilities are afraid of operating in violation of federal law."
However, considering that the United States' elderly population is
growing exponentially, creating a greater reliance on nursing homes and
skilled nursing facilities for elder care," the issue of medical marijuana
use in nursing homes is likely to grow.' 3
7. See Kurt Erickson, Missouri Says 'No' to Medical Marijuanain Veterans Nursing Homes,
ST.

LOUIS POST-DISPATCH

(Jan.

29,

2019),

https://www.stitoday.com/news/local/govt-and-

politics/missouri-says-no-to-medical-marijuana-in-veterans-nursing-homes/articled4d0c438-d9cc51cb-b182-68a125cae591.html (explaining that Missouri's seven veteran's nursing homes prohibit
medical marijuana use because it is not compliant with United States Department of Veteran Affairs
standards and, thus, may jeopardize federal funding); Samantha J. Gross, If You Need Medical
Marijuana, You

Better Not Be

in a Florida Nursing Home or ALF, MIA.

HERALD,

https://www.miamiherald.com/news/health-care/article227395904.html (Jan. 6, 2020, 4:30 PM)
(explaining that most Florida nursing homes and assisted living facilities ban medical marijuana due
to the fear of losing their federal Medicare and Medicaid funding).
8. Kathryn E. Hickner & Andrew J. Wilber, Medical Marijuana: Legal and Practical
Considerationsfor Hospitals, J. HEALTH & LIFE SCI. L., June 2019, at 39, 41; see also Jeremy

Berke & Skye Gould, Legal MarijuanaJust Went on Sale in Illinois. HereAre All the States Where
Cannabis is Legal, BUS. INSIDER (Jan. 1, 2020, 8:41 AM), https://www.businessinsider.com/legalmarijuana-states-2018-1.
9. See Genevieve Marie Razick & Zack S. Thompson, Department of PublicHealth, 32 GA.
ST. U. L. REV. 153, 172 (2015) (stating that nursing homes are "cautious and reluctant to allow a
federally banned substance," such as marijuana, in their facilities); Tim Regan, Senior Living
Providers Can No Longer Blow Off Pot Policies, SENIOR HOUS. NEWS (Apr. 19, 2018),
https://seniorhousingnews.com/2018/04/19/senior-living-providers-can-no-longer-blow-off-potpolicies (observing that many senior living facilities do not allow medical marijuana use in order to
adhere to federal and insurance guidelines).
10. See infra notes 291-300 and accompanying text.
11. 21 U.S.C. § 812(c) (Schedule I(c)(10)); Regan, supra note 9 (explaining that nursing
homes that receive federal funds are particularly reluctant to allow medical marijuana in their
facilities); Elizabeth S. Kase & Yulian Shtem, The New York Compassionate Care Act: High
Ambitions, Joint Risks, and Blunt Facts, in ASPATORE SPECIAL REPORT: A NON-SMOKING STATE:
NEW YORK'S MEDICAL MARIJUANA LAW EXPLAINED 5 (2016), Westlaw.
12. Karla Levinson, Comment, Long-Term Care Alert: An Analysis of Delaware'sApproach

to Medicaid Planning Techniques and Why Curbing Medicaid Planning Will Not Solve the
Nation's Long-Term Care Problem, 13 WIDENER L. REV. 223, 223 (2006) (explaining that "[t]his
demographic shift [to a generally older population] is beginning to put a strain on the nation's
resources for the elderly, especially in terms of long-term care. As the population ages, needs for
health care, long-term care, skilled-nursing, and assisted living facilities are increasing.").
13.

See Is Medical Marijuana Allowed in Nursing Homes or Assisted Living Communities?,

INHALEMD (Aug. 14, 2017), https://inhalemd.com/blog/medical-marijuana-allowed-nursing-homesassisted-living-communities ("Not only are seniors living longer, and accounting for a larger
percentage of the U.S. population-they're also becoming bigger consumers of Cannabis.
According to a study on demographic trends in marijuana use that was published less than a year
ago, 'The prevalence of past-year [C]annabis use among adults aged > 50 increased significantly

https://scholarlycommons.law.hofstra.edu/hlr/vol49/iss1/11
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Under the CSA, marijuana is classified as a Schedule I substance.14
This classification places marijuana in the same class of substances as
heroin, peyote, psilocybin, lysergic acid diethylamide (LSD), and
methylenedioxymethamphetamine (ecstasy)." Many states disagree with
this classification and have taken action to legalize medical marijuana in
order to aid in the treatment of certain medical conditions.1 6 Yet the
federal government has failed to follow suit.' 7 Though the federal
government has diverted resources away from prosecuting those who
use medical marijuana, 8 all forms of marijuana, with the exception of
hemp, are still banned under the CSA.1 9 This has led to situations where
the state government and federal government are in discord. 20 This
confusion ultimately only increases pain and frustration for elderly
citizens like Joy Seligman. 21
This Note will propose an exception, in limited circumstances, to
the federal government's classification of marijuana as a Schedule I
substance, 22 the intent being to grant access to medical marijuana to
patients residing in nursing homes or other skilled nursing facilities, who
qualify under their state's medical marijuana regulations.23 In Part II,
this Note will examine the CSA and the federal government's current
position on medical marijuana. 24 Part II will also explore the states'
varying approaches to the legalization of medical marijuana.25 This
analysis will primarily focus on New York and Florida as the two main
examples of states that have statutes legalizing medical marijuana
because both states have distinctive legislation that impacts the elderly
population residing in nursing homes. 26 Part III will explore the benefits
from 2006/07 to 2012/13, with a 57.8% relative increase for adults aged 50-64 . . and a 250%
relative increase for those aged > 65."' (alterations in original)).
14. § 812(c) (Schedule I(c)(10)).
15. Id. (Schedule I(b)(10), (c)(12), (c)(15), (c)(9), (c)(2)); Drug Scheduling, U.S. DRUG ENF'T
ADMIN., https://www.dea.gov/drug-scheduling (last visited Nov. 7, 2020).
16. See David F. Beach & Kristyn S. Appleby, Complex and Developing Liability Issues:
Legal Implicationsof Medical Marijuana,DRI FOR DEFENSE, Aug. 2015, at 42, 44-45, Westlaw, 57
No. 8 DRI FOR DEF. 42; Berke & Gould, supra note 8.
17. See infra Part IIB; Hickner & Wilber, supra note 8, at 42.
18. See infra Part II.B.2.
&

19. See § 812(c); FDA and Cannabis: Research and Drug Approval Process, U.S. FOOD
DRUG
ADMIN., https://www.fda.gov/news-events/public-health-focus/fda-and-marijuana
(last

updated Aug. 3, 2020) (explaining the legalization of hemp, which is a cannabis derivative).
20.

Heather Trela, Clash of Laws: The Growing Dissonance Between State and Federal

Marijuana Policies, ROCKEFELLER INST. OF Gov'T (Jan. 25, 2018), https://rockinst.org/issuearea/clash-laws-growing-dissonance-state-federal-marijuana-policies.
21. Seidman, supra note 1.
22. See infra Part IV.
23. See infra Part IV.
24. See infra Part II.B.

25. See infra Part II.C.
26. See infra Part II.C.
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27
of medical marijuana use amongst the elderly population. Part III will
also explore the barriers to accessing state-legalized medical marijuana
for people who reside in facilities, including nursing homes, assisted
28
living facilities, and other skilled nursing facilities. With the goal of
providing relief to the vulnerable elderly population by way of ensuring
access to medical marijuana, Part IV will provide the specific language
29
of the suggested exemption to the CSA.

II.

THE MEDICAL MARIJUANA DEBATE: THE STATES TAKE ON THE
FEDERAL GOVERNMENT

The Supremacy Clause of the United States Constitution establishes
that when federal law and state law contradict, "federal laws take
precedence over state laws."30 Yet, when it comes to medical marijuana,
many states are implementing their own regulations to legalize its
use-despite its illegality under the federal governing standard, the
CSA. 31 First, Subpart A will explain what is meant when the term
"medical marijuana" is used.32 Next, Subpart B will explore the federal
government's position on medical marijuana by examining the effect the
executive, legislative, and judicial branches have had on the legality of
medical marijuana.3 3 Finally, Subpart C will explore the states'
legalization of medical marijuana, despite its designation as a federally
banned substance under the CSA. 34 Subpart C will accomplish this by
highlighting Florida and New York as examples of states that have
implemented comprehensive medical marijuana regulations that directly
contradict federal law yet provide distinct benefits for residents of
35
nursing homes and assisted living communities.

27. See infra Part IIIA.
28. See infra Part III.B.
29.
30.

See infra PartIV.B.
Melanie Reid, The Quagmire that Nobody in the Federal Government Wants to Talk

About: Marijuana, 44 N.M. L. REv. 169, 188-89 (2014) (explaining the use of the Supremacy
Clause in enforcing the Controlled Substances Act ("CSA")); see U.S. CONST. art. VI, cl. 2; see also
Florence Shu-Acquaye, The Role of States in Shaping the Legal Debate on Medical Marijuana, 42
MITCHELL HAMLINE L. REv. 697, 738-39 (2016) (explaining the Supremacy Clause).
31. Moira Gibbons, The Cannabis Conundrum: Medication v. Regulation, HEALTH L., Dec.
2011, at 1, 7; see Berke & Gould, supra note 8 ("Eleven states and Washington, DC, have now

legalized marijuana for recreational use for adults over 21. And 33 states have legalized medical
marijuana.").

32.
33.
34.
35.

See infra Part I.A.
See infra Part II.B.
See infra Part I.C.
See infra Part II.C.
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What is Medical Marijuana?

Marijuana is a derivate of the flowering plant, cannabis. 36 There are
two main compounds found in marijuana. 37 The first is
delta-9-Tetrahydrocannabinol ("THC"), which is the main psychoactive
element of marijuana. 38 The second principal compound is cannabidiol
("CBD"), which generally does not have any psychoactive effects. 39
Depending on which portion of the cannabis plant is used, marijuana
products may have different levels of effectiveness, methods of use, and
differing psychoactive effects.40
In the United States, marijuana was first introduced for medicinal
purposes during the nineteenth century. 41 However, in other parts of the
world, the medicinal use of marijuana can be traced back to as early as
2700 BC. 42 Historically, there have been varied medical uses for
marijuana across the globe. 43 Today, marijuana is mainly utilized to treat
"ailments,
including:
nausea and vomiting
associated
with
chemotherapy; weight loss associated with AIDS; glaucoma; epilepsy;
muscle spasms and chronic pain in cases of multiple sclerosis,
quadriplegia and other spastic disorders; migraines; severe pruritus; and
depression and other mood disorders." 44 Nevertheless, each state that has
legalized marijuana for medical use may have slightly different
36. See Beach & Appleby, supra note 16, at 43; Gibbons, supra note 31, at 1 (explaining that
while marijuana is sometimes used to refer to the cannabis plant itself, "it is also generally used to
reference the parts of the plant that are ingested").

37. Beach & Appleby, supra note 16, at 43.
38. Id.
39. Id.
40. See id. (explaining that the delta-9-Tetrahydrocannabinol ("THC") in marijuana may have
"anti-nausea, anti-spasmodic, antioxidant, and appetite stimulating effects," while the cannabidiol
("CBD") may have "anti-inflammatory, antispasmodic, anti-anxiety, anticonvulsant, pain relief, and
possible anti-tumor capacities"); Gibbons, supra note 31, at 1 (describing the varying methods by
which marijuana may be consumed).
41.

See Melissa Brown, The Garden State Just Got Greener: New Jersey is the Fourteenth

State in the Nation to Legalize Medical Marijuana, 41 SETON HALL L. REV. 1519, 1523 (2011)
(explaining that, in the United States, marijuana was first recognized for its therapeutic potential and

was eventually prescribed for seizures, pain relief, restlessness, anxiety, and to distract those
suffering from terminal illnesses); Andrew J. LeVay, Note, Urgent Compassion: Medical
Marijuana, ProsecutorialDiscretion and the Medical Necessity Defense, 41 B.C. L. REV. 699,

701-02 (2000).
42. See Shu-Acquaye, supra note 30, at 701-02 (explaining that Chinese Emperor Shen Nung
is thought to have "discovered marijuana's healing properties" for use in the "treatment [of] gout,
malaria, and gas pain").
43. See id. at 702 (describing Egypt's use of marijuana to treat glaucoma and inflammation in
1213 BC, India's use of cannabis as an anesthetic and to treat leprosy, and ancient Greece's use of
marijuana "to treat earache, edema, and inflammation").

44.

See LeVay, supra note 41, at 702 (providing additional conditions that may benefit from

medical marijuana treatment, including "asthma, insomnia, dystonia, scleroderma, Crohn's Disease
and diabetic gastroparesis").
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definitions of what constitutes medical marijuana, or limits on which
portion of the cannabis plant the substance can be derived from and what
45
percentage of THC may make up the substance.
B.

The FederalGovernment's Position on Medical Marijuana

In recent years, the federal government has largely relaxed its
46
enforcement of the CSA against medical marijuana users. Yet at the
same time, the government has failed to reschedule marijuana from a
Schedule I substance. 47 Additionally, the Food and Drug Administration
("FDA") has yet to approve medical marijuana for any usage, even
though it had previously approved the cannabis derivate, CBD, for the
treatment of certain childhood-onset seizures and "three synthetic
cannabis-related drug products."48 Though the federal government
appears to have taken a hardline legislative stance against the use of
marijuana, demonstrated in both the CSA and the FDA's failure to
approve the substance, it has sent mixed messages regarding its position
49
on medical marijuana by relaxing enforcement efforts. This Note will
evaluate the approaches of the executive, legislative, and judicial
50
branches in responding to the legality of medical marijuana.
1. The CSA
5
In 1970, Congress enacted the CSA. ' The CSA categorizes
controlled substances into schedules "based on their accepted medical
uses, the potential for abuse, and their psychological and physical effects
on the body."52 There are five schedules under the CSA-I, II, III, IV,
45. See Beach & Appleby, supra note 16, at 44 (stating that under Florida law, medical grade
marijuana means "a substance that contains no more than 0.5 percent or less of any THC and at least

15 percent CBD"). Compare TEX. Occ. CODE ANN. § 169.001(3) (West 2019) (defining medical
marijuana as "the plant Cannabis sativa L., and any part of that plant or any compound,
manufacture, salt, derivative, mixture, preparation, resin, or oil of that plant that contains not more
than 0.5 percent by weight of tetrahydrocannabinols"), with VT. STAT. ANN. tit. 18, § 4472(20)
(West 2019) (defining "[u]sable marijuana" under Vermont's medical marijuana statute as "the
dried leaves and flowers of marijuana, and any mixture or preparation thereof, and does not include
the seeds, stalks, and roots of the plant").
46. Hickner & Wilber, supra note 8, at 43.
47.

Anushree Madappa, Marijuana to Stay a Schedule I Drug, Federal Judge Denies

Reclassification, INT'L BUS. TIMEs (Feb. 27, 2018, 6:34 AM), https://www.ibtimes.com/marijuana9
stay-schedule-i-drug-federal-judge-denies-reclassification-26578 0.
48.

See FDA and Cannabis:Research and Drug Approval Process,supra note 19.

49. See Controlled Substances Act, 21 U.S.C. § 812; Hickner & Wilber, supra note 8, at 43;
Gibbons, supra note 31, at 5-6 (explaining that the federal government has not taken a consistent
approach to marijuana enforcement).
50. See infra Part II.B.1-5.
51. Controlled Substances Act, Pub. L. 91-513, 84 Stat. 1242 (1970) (codified as amended at
21 U.S.C. §§ 801-904); Shu-Acquaye, supra note 30, at 698.
52. Brown, supra note 41, at 1537 (quoting Gonzales v. Raich, 545 U.S. 1, 13 (2005)); see
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and V, with Schedule V controlled substances being the least likely to
carry an abuse risk. 53 Currently, marijuana is classified as a Schedule I
substance.54 A substance may be classified as a Schedule I substance if it
"has a high potential for abuse," if it does not have a "currently accepted
medical use in treatment," or if "[t]here is a lack of accepted safety for
use of the drug or other substance under medical supervision." 5
Marijuana's scheduling as a Schedule I substance does not only
affect those that use marijuana recreationally, but it also causes liability
issues for health care providers. 56 As per the CSA, it is a criminal
offense to knowingly or intentionally manufacture, distribute, dispense,
or possess marijuana for any purpose, including for medical use, with
the sole exception being use of the drug as part of an FDA preapproved
research study.57 As such, "physicians may not prescribe and
pharmacists are precluded from dispensing marijuana."5 8 Petitions to the
Drug Enforcement Agency ("DEA") and Attorneys General to
reschedule marijuana, or to remove it from the CSA altogether, have,
thus far, proven unsuccessful. 59
2. Additional Congressional Action
In recent years, Congress has attempted to loosen the impact of the
CSA on medical marijuana use. 60 Even characteristically conservative
states have representatives in Congress who have pledged their support
for the legalization of marijuana for medical use. 61 However, despite a
general advancement in Congress's attitude towards medical marijuana,
when presented with bills that would legalize it, Congress has failed to
act on a majority of the legislation. 62
also 21 U.S.C. § 812(b).
53. See § 812(b), (b)(5)(A).
54. Id. § 812(c) (Schedule I(c)(10)).
55. See id. § 812(bXl); see also § 811 (outlining that the Attorney General has the discretion
to add, or remove, a section 812 substance if he finds that it fits the parameters of a schedule).
56. See Beach & Appleby, supra note 16, at 42-43.
57. See §§ 823(f), 841(a)(1), 844(a); see Gonzales, 545 U.S. at 14.
58. Brown, supra note 41, at 1537.
59.

See Mason Marks, Psychedelic Medicinefor Mental Illness and Substance Use Disorders:

Overcoming Social and Legal Obstacles, 21 N.Y.U. J. LEGIS. & PUB. POL'Y 69, 91 (2018);
Madappa, supranote 47.
60. See Gibbons, supra note 31, at 6.
61.

(Mar.

See Katy Steinmetz, Senators Introduce HistoricBill to Allow Medical Marijuana,TIME

10, 2015,

1:55 PM), https://time.com/3738038/medical-marijuana-congress;

Timothy

Fanning, Florida'sNursing and AssistedLiving Homes Don't Do Medical Pot, HERALD-TRIB. (June

23, 2019, 5:28 AM), https://www.heraldtribune.com/news/20190623/floridas-nursing-and-assistedliving-homes-dont-do-medical-pot.
62. See Tom Angell, Congressional Bills Affecting Cannabis Laws Go to Conference
Committees, MARIJUANA MOMENT (July 19, 2018), https://www.marijuanamoment.net/congression
al-bills-affecting-cannabis-laws-go-to-conference-committees;
Gibbons, supra note 31, at 6;

Published by Scholarly Commons at Hofstra Law, 2020

7

Hofstra Law Review, Vol. 49, Iss. 1 [2020], Art. 11

282

HOFSTRA LAW REVIEW

[Vol. 49:275

One exception is the Rohrabacher Amendment, which was included
in the Consolidated and Further Continuing Appropriations Act of
2015.63 Passed in 2015, this amendment to the federal budget prohibited
the Department of Justice ("DOJ") from using funds passed in its budget
appropriations to prohibit states that have legalized medical marijuana
"from implementing their own laws that authorize the use, distribution,
possession, or cultivation of medical marijuana."' Congress has
renewed this resolution yearly in its Consolidated Appropriations Acts,
in which it also provides an updated list of the states that the DOJ may
not target. 65 Though the Rohrabacher Amendment did not legalize
medical marijuana, it sent a signal "that the federal government will
66
generally not interfere with state medical marijuana programs."
However, it has been held that if an individual or facility does not
"strictly comply" with their state's medical marijuana laws, that entity
has "engaged in conduct that is unauthorized, and prosecuting such
67
individuals does not violate [the Rohrabacher Amendment]."
Despite the Rohrabacher Amendment's success, legislators are
faced with increasing pressure to take steps to legalize medical
marijuana from a growing percentage of constituents who support the
68
legalization of medical marijuana. This pressure seems to have had an
impact on Congress as there has been a continuum of bills introduced
69
However, Congress
that would impact the legality of marijuana.
continues to send mixed messages, as all of the bills introduced to date
have stalled in committee. 70
Steinmetz, supra note 61 (demonstrating an advancement in Congress's attitude towards medical

marijuana legislation).
63. Consolidated and Further Continuing Appropriations Act, 2015, Pub. L. No. 113-235, 128
Stat. 2130 (2015).
64. Id. § 538, 128 Stat. at 2217.
65. See Consolidated Appropriations Act, 2016, Pub. L. No. 114-113, § 542, 129 Stat. 2242,
2332-33 (2016); Consolidated Appropriations Act, 2017, Pub. L. No. 115-31, § 537, 131 Stat. 135,
228 (2017); Consolidated Appropriations Act, 2018, Pub. L. No. 115-141, § 538, 132 Stat. 348,
444-45 (2018); Consolidated Appropriations Act, 2019, Pub. L. No. 116-6, § 537, 133 Stat. 13, 138
(2019); Consolidated Appropriations Act, 2020, Pub. L. No, 116-93, § 531, 133 Stat. 2317, 2431
(2019).
66. Hickner & Wilber, supra note 8, at 43.
67. Id. (alteration in original) (quoting United States v. McIntosh, 833 F.3d 1163, 1178 (9th
Cir. 2016)).
68. See Andrew Daniller, Two-Thirds of Americans Support Marijuana Legalization, PEW
RSCH. CTR. (Nov. 14, 2019), https://www.pewresearch.org/fact-tank/2019/11/14/americans-supportmarijuana-legalization; Steinmetz, supra note 61.
69. See Gibbons, supra note 31, at 7; Steinmetz, supra note 61; Tom Angell, US Attorney

General Says He Prefers MarijuanaReform Bill to Current Federal Law, BOs. GLOBE (Apr. 10,
2019, 12:47 PM), https://www.bostonglobe.com/news/marijuana/2019/04/10/attorney-general-saysprefers-marijuana-reform-bill-current-federal-law/XdagmJ2aAA5EYWTFmXWubK/story.html.
70. See CARERS Act of 2019, H.R. 127, 116th Cong. (2019); Responsibly Addressing the
Marijuana Policy Gap Act of 2019, S. 421, 116th Cong. (2019); States' Medical Marijuana Patient

https://scholarlycommons.law.hofstra.edu/hlr/vol49/iss1/11

8

Vaiana: Give Grandma Her Ganja: Exploring the Need for an Exception to th

GIVE GRANDMA HER GANJA

2020]

283

For instance, in a 2011 major proposal, the States' Medical
Marijuana Patient Protection Act, was introduced in Congress. 71 This bill
recommended that marijuana be rescheduled under the CSA and
provided that the CSA would not restrict the use of medical marijuana if
its use was in compliance with state law. 72 However, after the bill was
referred to the Subcommittee on Health in 2011, no further action was
taken. 73 Subsequently, in 2013, the same bill was reintroduced in
Congress. 74 This time, the bill was referred to the Subcommittee on
Crime, Terrorism, Homeland Security, and Investigations but, again, no
further action has been taken. 75 Furthermore, in 2019, several more bills
pertaining to medical marijuana were introduced in Congress. 76 These
bills demonstrate that there is an increased interest in accommodating
medical marijuana use, and while most bills have been referred to
subcommittees, none have passed the House or the Senate as of
September 2020.77
Protection Act, H.R. 1983, 112th Cong. (2011); States' Medical Marijuana Patient Protection Act,
H.R. 689, 113th Cong. (2013); Veterans Cannabis Use for Safe Healing Act, H.R. 2191, 116th
Cong. (2019). But see Veterans Equal Access Act, H.R. 1647, 116th Cong. (2019) (passing in the
House Committee on Veteran's Affairs but yet to progress to the House for a full vote); MORE Act

of 2019, H.R. 3384, 116th Cong. (2019) (passing in the House Judiciary Committee and pending
vote in the House).
71. H.R. 1983.
72. See id.
73.

H.R.

1983 - States' Medical Marijuana Patient Protection Act,

https://www.congress.gov/bill112th-congress/house-bill/1983/all-actions
2020).
74. H.R. 689.
75. H.R.

(last

CONGRESS.GOV,

visited

689 - States' Medical Marijuana Patient Protection Act,

Nov.

7,

CONGRESS.GOV,

https://www.congress.gov/bill/113th-congress/house-bil/689/all-actions (last visited Nov. 7, 2020).
76. See CARERS Act of 2019, H.R. 127, 116th Cong. (2019) ("To extend the principle of
federalism to State drug policy, provide access to medical marijuana, and enable research into the
medicinal properties of marijuana."); Responsibly Addressing the Marijuana Policy Gap Act of
2019, S. 421, 116th Cong. (2019) ("To amend the [CSA] to reduce the gap between Federal and
State marijuana policy, and for other purposes."); Veterans Equal Access Act, H.R. 1647, 116th
Cong. (2019) ("To authorize Department of Veteran Affairs health care providers to provide
recommendations and opinions to veterans regarding participation in State marijuana programs.");

MORE Act of 2019, H.R. 3384, 116th Cong. (2019) ("To decriminalize and deschedule cannabis, to
provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for
expungement of certain cannabis offenses, and for other purposes.").
77. See H.R. 127 - CARERS Act of2019, CONGRESS.GOV, https://www.congress.gov/bill/116

th-congress/house-bilU/127/all-actions (last visited Nov. 7, 2020); S. 421 - Responsibly Addressing
the Marijuana Policy Gap Act of 2019, CONGRESS.GOV, https://www.congress.gov/bill/ 16thcongress/senate-bill/421/all-actions (last visited Nov. 7, 2020); H.R. 1647 - Veterans Equal Access
Act, CONGRESS.GOV, https://www.congress.gov/bill/U16th-congress/house-bill/i647/all-actions (last
visited Nov. 7, 2020); but see H.R. 3884 - Marijuana Opportunity Reinvestment and Expungement

Act of 2019, CONGRESS.GOV, https://www.congress.gov/bill/116th-congress/house-bill/3884/allactions (last visited Nov. 7, 2020); Bobby Gehlen, Landmark Bill DecriminalizingMarijuanaat the
Federal Level

Passes House

Committee,

ABC

NEWS

(Nov.

20,

2019,

https://abcnews.go.com/Politics/house-judiciary-passes-bill-legalize-marijuana-federal-
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3. The Influence of the Attorneys General
The executive branch has also had an impact on the medical
marijuana debate through its administrative agencies, especially the
DOJ.78 Throughout the Obama and Trump administrations, memoranda
released by the Unites States Attorney General have added to the
confusion surrounding federal enforcement of the CSA's prohibition of
medical marijuana.79 During the Trump administration alone, there have
been two Attorneys General with two different positions on medical
80
marijuana enforcement. This confusion becomes problematic because
it leaves caregivers, distributers, manufacturers, and medical marijuana
users wary of participating in state-sanctioned medical marijuana
81
programs due to the fear of federal prosecution.
The problem first began in 2009 under the Obama administration,
when then Unites States Deputy Attorney General David W. Ogden sent
82
what is known as the "Ogden Memo." The Ogden Memo was sent "to
federal prosecutors encouraging them not to prosecute people who
distribute marijuana for medical purposes in accordance with state
law."8 3 Though the Ogden Memo did not legalize marijuana, it

-

d=67174950 (explaining that the Marijuana Opportunity Reinvestment and Expungement
("MORE") Act of 2019 (H.R. 3884) was passed in the House Judiciary Committee and that this is
"the first time a congressional committee has passed a bill in favor of decriminalizing marijuana at
the federal level. [However,] it will still need to pass the full House before moving to the [S]enate
where it is likely to stall"); Meredith Deliso, Bill to Decriminalize Marijuana at Federal Level up
PM),
4:49
30, 2020,
(Aug.
NEWS
ABC
Month,
Next
Vote
for House
https://abcnews.go.com/Politics/bill-decriminalize-marijuana-federal-level-house-vote- month/story
?id=72714766 (reporting that, though the MORE Act is up for vote in the House in September
2020, President Trump and Republican Majority Leader Mitch McConnell do not support the
legislation, making it less likely to be successful); Alexander Lekhtman, Why Historic House
23, 2020),
FILTER (Sept.
Vote Has Been Pushed Back,
Legalization
https://filtermag.org/democrats-marijuana-legalization-delay (reporting that the House vote for the
MORE Act has "been pushed back until sometime after the [2020 election]").
78. See infra notes 79-101 and accompanying text.
79. See Reid, supra note 30, at 179-80 (explaining how a series of memoranda from the
United States Deputy Attorney General led to confusion amongst prosecutors and Department of
Justice ("DOJ") agents during the Obama administration); Angell, supra note 69 (explaining the
Marijuana

responses by the Trump administration's Attorney General); Tom Firestone, 2 Years After Sessions
Cole Memo, Prosecutors Continue to Adhere to Obama-Era Enforcement Guidelines, BENZINGA
2

(Jan. 8, 2020, 12:24 PM), https://www.benzinga.com/markets/cannabis/ 0/01/15093079/2-years-memo-prosecutors-continue-to-adhere-to-obama-era-enforceme
after-sessions-rescinded-cole
(stating that even though former Attorney General Jeff Sessions rescinded various Obama era
guidance on the enforcement of marijuana enforcement in 2018, the DOJ cases brought after that
show that the Trump administration largely adhered to the Obama administration's policies); see

also infra notes 82-101 and accompanying text.
80.

See infra notes 92-99 and accompanying text.

81. See Joseph Gregorio, Physicians, Medical Marijuana, and the Law, 16 AMA J. ETHICS
732, 733 (2014).
82. Shu-Acquaye, supra note 30, at 739.
to
83. Id.; see Memorandum from David w. Ogden, Deputy Att'y Gen., U.S. Dep't 2of00J.,
9
/10
Selected U.S. Att'ys (Oct. 19, 2009), https://www.justice.gov/sites/defaultt/files/opa/legacy/
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encouraged federal prosecutors to divert their enforcement efforts
elsewhere and not to focus on prosecuting individuals and their
caregivers who were using marijuana for medicinal purposes. 84 The
Ogden Memo was encouraging to those in need of medicinal marijuana
and gave states the leeway to continue to develop medical marijuana
programs-irrespective of the CSA's prohibition on marijuana.8 5
However, in 2011, United States attorney Melinda Haag sent a
letter in which she encouraged vigorous enforcement of the CSA. 86 This
letter led to a series of letters from other attorneys, who also encouraged
the enforcement of the CSA and federal raids in multiple states,
signaling a deviation from the Ogden Memo. 87 In response to the
confusion spurred by these letters, United States Deputy Attorney
General James Cole released his own memoranda, one in June of 2011
(the "2011 Cole Memo") and one in August of 2013 (the "2013 Cole
Memo"). 88 The Cole memoranda echoed the sentiment of the Ogden
Memo by again emphasizing that prosecuting seriously ill individuals
and their caregivers was not an efficient use of federal resources. 89
However, the 2011 Cole Memo specified that caregivers were only
considered to be those caring for the "seriously ill, not commercial
operations cultivating, selling or distributing marijuana."90 Though the
2013 Cole Memo clarified that prosecutors should "review marijuana
cases on a case-by-case basis," the Cole Memos created fear among

/19/medical-marijuana.pdf.
84.
85.
86.
Russo,

See Memorandum from David W. Ogden, supra note 83; Trela, supra note 20.
See Shu-Acquaye, supra note 30, at 740.
See Letter from Melinda Haag, U.S. Att'y for the N. Dist. of Cal., U.S. Dep't of J., to John

Oakland

City

Att'y

(Feb.

1,

2011),

https://www.azmarijuanalaw.com/wp-

content/uploads/2011/03/Melinda-Haag-Letter-110201.pdf (explaining that, while the DOJ does
"not focus its limited resources on seriously ill individuals who use marijuana as part of a medically
recommended treatment regimen in compliance with state law . . . [the DOJ] will enforce the CSA
vigorously against individuals and organizations that participate in unlawful manufacturing and
distribution activity involving marijuana, even where such activities are permitted under state law").
87. See Shu-Acquaye, supra note 30, at 741.
88. Id. at 741-43 (explaining that United States Deputy Attorney General James M. Cole
released a memorandum in 2011, clarifying the DOJ's marijuana policy, and subsequently released
a second memorandum in 2013, updating this policy); Memorandum from James M. Cole, Deputy
Att'y
General,
U.S.
Dep't
of
J.,
to
U.S.
Att'ys
(June
29,
2011),
https://www.justice.gov/sites/default/fi
les/oip/legacy/2014/07/23/dag-guidance-2011-for-medicalmarijuana-use.pdf [hereinafter 2011 Cole Memo]; Memorandum from James M. Cole, Deputy Att'y
General,
U.S.
Dep't
of
J.,
to
U.S.
Att'ys
(Aug.
29,
2013),
https://www.justice.gov/iso/opa/resources/305201382913275685 7467.pdf [hereinafter 2013 Cole
Memo].
89. See 2011 Cole Memo, supra note 88; 2013 Cole Memo, supra note 88; Trela, supra note
20.
90. 2011 Cole Memo, supra note 88, at 1.
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medical marijuana users that the federal government would restrict their
9
access and encourage prosecution of their caregivers. 1
Amplifying this fear, in 2018, in the midst of the burgeoning
Trump administration, then-Attorney General Jeff Sessions completely
92
In his
rescinded the Obama era administration's memoranda.
Sessions
General
Attorney
Memo"),
"Sessions
(the
memorandum
directed federal prosecutors to use agency policies and discretion to
93
decide which marijuana crimes to prosecute. Though this memo did
not directly require the enforcement of the CSA against medical
marijuana users, it left many unsettled, wondering whether users of
94
medical marijuana would be the target of federal prosecution.
Finally, in 2019, amidst a change in administration officials,
then-nominee for United States Attorney General, William Barr,
renounced the Sessions Memo and pledged to adhere to the suggested
95
practice in the Cole Memo. This meant that, once again, federal
prosecutors would be instructed not to focus on "parties who have
96
complied with state law in reliance on the Cole Memorandum." As
Attorney General, William Barr stated that, while he does not intend to
legalize marijuana under the CSA, he believes that Congress needs to
97
address marijuana on a federal level. Additionally, Attorney General
Barr confirmed that he planned to increase the number of legalized
98
"cannabis manufactures for research purposes." Though he has failed
91. 2013 Cole Memo, supra note 88, at 3; see Shu-Acquaye, supra note 30, at 742-43
(explaining that both the 2011 Cole Memo and the 2013 Cole Memo show that the DOJ will not
hesitate to act if the states are unable to moderate marijuana activity appropriately). Laura Jarrett,
Sessions Nixes Obama-EraRules Leaving States Alone that Legalize Pot, CNN (Jan. 4, 2018, 5:44

PM), https://www.cnn.com/2018/01/04/politics/jeff-sessions-cole-memo/index.html; Memorandum
from Jefferson B. Sessions, Att'y General, U.S. Dep't of J., to all U.S. Attorneys (Jan. 4, 2018),
22
196/download.
https://www.justice.gov/opa/press-release/file/10
to all U.S. Attorneys, supra note 91; Jarrett,
Sessions
B.
Jefferson
from
92. See Memorandum
supra note 91.

93. See Memorandum from Jefferson B. Sessions to all U.S. Attorneys, supra note 91; Jarrett,
supra note 91.
94. See Jarrett, supra note 91; see Trela, supranote 20.

in
95. Tom Angell, Trump Attorney General Pick Puts Marijuana Enforcement 9Pledge
28
/tru
/01/
https://www.forbes.com/sites/tomangell/201
PM),
1:23
2019,
28,
(Jan.
FORBES
Writing,
mp-attorney-general-pick-puts-marijuana-enforcement-pledge-in-writing.

96. Id.
97.

Angell, supra note 95; see Angell, supra note 69 (explaining that Attorney General Barr

believes that the legalization of marijuana is a legislative issue that should be determined by
Congress, not the DOJ. Barr stated "that he would prefer that Congress enact legislation allowing

states to legalize marijuana instead of continuing the current approach under which a growing
number of states have ended cannabis prohibition in conflict with federal law").
98.

Angell, supra note 69; see FDA and Cannabis: Research and Drug Approval Process,

supra note 19 (explaining that the federal government, through the Food and Drug Administration
("FDA") and Drug Enforcement Agency ("DEA"), permits certain marijuana manufacturers to
cultivate marijuana in order participate in clinical research without facing punishment under the

CSA and that, at this time, only the University of Mississippi is permitted to cultivate marijuana for
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to reschedule marijuana, these actions support Attorney General Barr's
claim that he "does not plan to dedicate Justice Department resources to
enforcing federal cannabis laws to crack down on the legal industry." 99
Though Attorney General Barr's statements appear to indicate that
state-sanctioned medical marijuana users will not be prosecuted under
federal law, marijuana is still a Schedule I substance under the CSA.1 00
The frequent shift in the DOJ's position on medical marijuana has
demonstrated that there is a need for a federal standard and legislative
protections for those who use medical marijuana in compliance with
their state's laws. 101
4. The FDA's Influence
Another administrative agency that has had an impact on the
accessibility of medical marijuana is the FDA. 102 In 1978, the National
Institute on Drug Abuse and the FDA implemented the Compassionate
Investigational New Drug program, 103 which permitted the government
to provide marijuana to individuals suffering from certain illnesses while
researching its effects.104 However, "in 1992, President George W. Bush
ordered the closure of the Compassionate Investigational New Drug
Program." 10 5 This closure had a lasting effect as the FDA has never
reopened the program and no longer has a system of supplying patients
with medical marijuana.1%
research purposes).
99.

Angell, supra note 69.

100. See 21 U.S.C.
101.
102.

§ 812(c)

(Schedule I(c)(10)); Angell, supra note 95.

See Reid, supra note 30, at 179-80; see also Angell, supra note 69.
See Erika M. Medina, Unable to Exhale: CUMMA and FederalHealthcare Regulation,

N.J. L., Oct. 2018, at 22, 23 (explaining that "[t]he FDA is [the agency] in charge of reviewing
products intended to diagnose, cure, mitigate, treat or prevent a disease and, upon confirmation,
classifying the products as a drug").
103. Mark S. Lally, What's in Storefor Delaware'sFirst Medical Cannabis Dispensary,DEL.

L., Spring 2015, at 20, 21; Patricia D. Smith & Andrew P. Lannon, Local Regulation of Medical
Marijuana in Florida, FLA. B.J., Nov. 2017, at 59, 59; Provision of Marijuana and Other
Compounds for Scientific Research - Recommendations, NAT'L INST. ON DRUG ABUSE (Jan. 1998),

https://archives.drugabuse.gov/advisory-council-minutes/provision-marijuana-other-compoundsscientific-research-recommendations.
104. See Lally, supra note 103, at 21 (explaining that "[t]he [Compassionate Investigational

New Drug] program offered relief to AIDS patients, as well as those suffering with other diseases
like glaucoma and bone tumors"); Shu-Acquaye, supra note 30, at 736-37. The Compassionate

Investigational New Drug program was inspired by individuals like "Robert Randall, a
twenty-eight-year-old glaucoma patient," who petitioned the federal government to use
"government marijuana, grown for research, to aid in his treatment of glaucoma." Shu-Acquaye,
supra note 30, at 737.
105. See Smith & Lannon, supra note 103, at 60.
106. LeVay, supra note 41, at 705 (writing that "[t]he [Compassionate Investigational New
Drug] program remains suspended today with no additional patients admitted since 1992"); Daniel
Oberhaus, The US Government Has Sent This Guy 300 Joints Each Monthfor 34 Years, VICE (Sept.
9, 2016, 12:00 AM), https://www.vice.com/enus/article/dp3e4y/the-us-government-has-sent-this-

Published by Scholarly Commons at Hofstra Law, 2020

13

Hofstra Law Review, Vol. 49, Iss. 1 [2020], Art. 11

HOFSTRA LAW REVIEW

288

[Vol. 49:275

Recently, the FDA acknowledged that there has been considerable
"interest in the potential utility of cannabis for a variety of medical
conditions" and that several states now permit the use of medical
marijuana. 107 Despite this acknowledgement, the FDA has only
approved one cannabis-derived drug product (Epidiolex) and three
synthetic cannabis-related drug products (Marinol, Syndros, and
Cesamet) as "safe and effective," failing to deem marijuana itself as safe
and effective. 108 The reasoning behind the FDA's reluctance to classify
any marijuana product as a "safe and effective" drug is primarily due to
its classification as a Schedule I substance.1 09 This classification means
that, in the eyes of the federal government, there is a "lack of scientific
0
evidence proving [marijuana's] efficacy" for medical treatment" and
1
that there is no accepted medical use in treatment. "'
The FDA's decision not to approve marijuana for medical use has
2
had a direct impact on medical marijuana users." Since medical
marijuana is not FDA-approved, it cannot be classified as a "drug" for
use in medical treatment.' 3 Therefore, while a physician may be
permitted to authorize a patient's use of medical marijuana under state
law, the physician cannot provide a prescription for marijuana and the
4
patient cannot obtain the marijuana from a pharmacy." Instead, the
patient has to "purchase the marijuana from an authorized treatment
center."'"5 Furthermore, the cost of the marijuana cannot be covered by
6
the patient's health insurance because it is not a prescription drug."1
Aside from making the process of obtaining medical marijuana more
difficult, the FDA's failure to approve marijuana for medical use also
raises the cost of obtaining medical marijuana and causes some patients
7
to resort to using illegally-obtained marijuana."
guy-300-joints-each-month-for-34-years (stating that "only [thirteen] patients were grandfathered
in" to the Compassionate Investigational New Drug program before the program ended in 1992).
107.

FDA and Cannabis: Research and Drug Approval Process, supra note 19; see FDA

Regulation of Cannabis and Cannabis-DerivedProducts, Including Cannabidiol(CBD), U.S. FOOD
& DRUG ADMIN. (Aug. 3, 2020), https://www.fda.gov/news-events/expanded-access/expandedaccess-keywords-definitions-and- resources.
108. FDA and Cannabis: Research and Drug Approval Process, supra note 19; see Marks,
supra note 59, at 91-92.
109. See Marks, supra note 59, at 91-93.
110. Id. at 91, 107-09 (discussing the rigorous procedures for conducting clinical trials of
Schedule I substances, which inhibit the general availability of scientific research on substances
such as marijuana).
111. Controlled Substances Act, 21 U.S.C. § 812(b)(1)(C); see Medina, supra note 102, at 23.
112. See Medina, supranote 102, at 22-23.
113. See id. at 23.
114. See id.; Hickner & wilber, supra note 8, at 42, 49 n.25.
115. Medina, supra note 102, at 23.
116. Id.
117. See Sam P.K. Collins, The High Price of Medical Marijuana Is Forcing People Back to
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Intriguingly, despite its failure to approve medical marijuana, the
FDA has approved medications that are comparable to, and contain
properties of, marijuana."' For instance, the FDA has approved two
medications "based on synthetic THC (Marinol and Cesamet)."1 19 The
FDA has also approved a medication, Epidiolex, which contains the
cannabis derivative CBD, specifically to treat two severe forms of
epilepsy frequently diagnosed in children. 120 Shortly after approving
Epidiolex, the DEA classified Epidiolex as a Schedule V substance
under the CSA. 121 The DEA clarified that marijuana and CBD are still
illegal substances, but that the DEA followed the FDA's guidance and
legalized Epidiolex because the FDA "determined there is a medically
approved benefit." 12 2 The FDA's approval led the way for Epidiolex to
be prescribed by physicians and may encourage an increase of "research
into other marijuana-derived medicines."1 23
The FDA has made some efforts to provide a pathway for access to
medical marijuana in the future.1 24 For instance, it has provided
the Black Market, THINKPROGRESS (Sept. 21, 2015, 6:37 PM), https://thinkprogress.org/the-highprice-of-medical-marijuana-is-forcing-people-back-to-the-black-market-955bl481e234
(explaining
that marijuana's designation as a Schedule I substance and the FDA's failure to approve medical
marijuana as a safe and effective drug are two significant factors that contribute to the high cost of
medical marijuana, which results in some patients resorting to buying marijuana "on the black
market").
118. See Marks, supra note 59, at 90-91.
119. DAVID EvANS, DRUG TESTING LAW TECH. & PRAc. § 1:115, Westlaw DRUGTEST
(database updated Nov. 2020); see Beach & Appleby, supra note 16, at 3 (explaining that Cesamet,
also known as Nabilone, is a synthetic compound of cannabis "approved for use by the FDA in
1985 for the treatment of nausea and vomiting caused by chemotherapy"); Marks, supra note 59, at
90 (describing Marinol as an "FDA-approved medication" that contains the generic version of THC,
dronabinol, used "for treating AIDS-associated appetite loss and nausea and vomiting associated
with cancer chemotherapy").

120. Press Release, U.S. Food & Drug Admin., FDA Approves First Drug Comprised of an
Active Ingredient Derived from Marijuana to Treat Rare, Severe Forms of Epilepsy (June 25, 2018),
https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-comprised-activeingredient-derived-marijuana-treat-rare-severe-forms
(announcing that the FDA approved
Epidiolex, "the first FDA-approved drug that contains a purified drug substance derived from
marijuana," for the treatment of "two rare and severe forms of epilepsy, Lennox-Gastaut syndrome

and Dravet syndrome, in patients two years of age and older.").
121. FDA-Approved Drug Epidiolex Placed in Schedule V of Controlled Substance Act, U.S.
DRUG ENF'T ADmiN. (Sept. 27, 2018), https://www.dea.gov/press-releases/2018/09/27/fdaapproved-drug-epidiolex-placed-schedule-v-controlled-substance-act; see 21 U.S.C. § 812(b)(5)
(providing that a substance is classified as a Schedule v substance if it has a comparatively "low
potential for abuse," "a currently accepted medical use," and abuse of the drug "may lead to limited
physical dependence or psychological dependence").
122. FDA-Approved Drug Epidiolex Placed in Schedule V of Controlled Substance Act, supra

note 121.
123. Erin Brodwin, A Drug Derivedfrom MarijuanaHas Triggered the First FederalShift on
Cannabisin Half a Century, andExperts Predictan Avalanche Effect, BUS. INSIDER (Sep. 27, 2018,

10:56 AM), https://www.businessinsider.com/marijuana-epilepsy-drug-approved-dea-cbd-2018-9.
124. FDA and Cannabis:Research and DrugApproval Process, supra note 19.
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procedures that facilitate limited clinical trials, which scientifically test
marijuana use in humans, and experimental treatments for "patients with
serious diseases or conditions when there is no comparable or
12 5
However, these procedures
satisfactory alternative therapy available."
New Drug
Investigational
Compassionate
the
than
are different
12 6
to
marijuana
supplying
government
Now, instead of the
program.
12 8
12
access"
"expanded
for
eligible patients, 1 the FDA offers applications
129
These programs
and "Investigational New Drugs" ("IND") programs.
permit manufacturers to supply patients with access to medications that
have not yet been determined "to be safe and effective" for treatment in
130
This could, at times, include
serious or emergent situations.
131
specifically medical marijuana
not
are
but these programs
marijuana,
13 2
programs. The FDA has also collaborated with several states that have
permitted medical marijuana use in order to ensure that their medical
3
research complies with federal requirements."
Moreover, the CSA's scheduling of marijuana as a Schedule I
substance limits research and the FDA's ability to approve marijuana for
medical use. 3 4 Notably, the FDA has made some efforts to allow for
further research into the safety and effectiveness of medical marijuana,
despite its illegality." 5 These efforts to advance marijuana research have

125. Id.
126. See Smith & Lannon, supra note 103, at 60 (discussing the Compassionate Investigational
New Drug program).
127. See Lally, supra note 103, at 21.
2020),
27,
(Apr.
& DRUG ADMIN.
FOOD
U.S.
128. Expanded Access,
https://www.fda.gov/news-events/public-health-focus/expanded-access (explaining that the FDA's
expanded access program operates as "a potential pathway for a patient with an immediately

life-threatening condition or serious disease or condition to gain access to an investigation's medical
product (drug, biologic, or medical device) for treatment outside of clinical trials when no
comparable or satisfactory alternative therapy options are available").
129. Investigational New Drug (IND) Application, U.S. FOOD & DRUG ADMIN. (May 12,
https://www.fda.gov/drugs/types-applications/investigational-new-drug-ind-application
2020),
(explaining the FDA's current Investigational New Drugs program).
130.

Expanded Access, supra note 128; see InvestigationalNew Drug (IND) Application, supra

note 129.
131. Hickner & wilber, supra note 8, at 48 (mentioning that some hospitals allow for medical
marijuana use by patients participating in the FDA's expanded access program); FDA and
Cannabis:Research and Drug Approval Process, supra note 19.

132. See generally Expanded Access, supra note 128 (explaining that the program provides
access to investigational medical products including "drug[s], biologic[s], or medical device[s]," as
well as the process and requirements for applying for the expanded access program); Investigational
New Drug (IND) Application, supra note 129 (describing the process and requirements for
completing the FDA's Investigational New Drug application, which apply to qualifying
"investigational drug[s]" or "experimental drugs").
133. Medina, supranote 102, at 23.
134. See Marks, supra note 59, at 93, 97, 108-09.
135.

See FDA and Cannabis:Research and Drug Approval Process,supra note 19.
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the potential to have a great impact on the accessibility of medical
marijuana for many individuals. 136
5. The Judiciary's View
While the support of the legislative and the executive branches has
wavered with regard to the use and legality of medical marijuana, the
judicial branch has been firmer in its interpretation of marijuana
policy. 137 The courts have generally maintained that the CSA is the
prevailing federal law on the issue of marijuana and that the CSA
preempts state law. 138 This Note will review several cases that have
demonstrated the federal judiciary's interpretation of the CSA on
medical marijuana use.139
4 0
In United States v. Oakland CannabisBuyers' Cooperation,"
the
United States sued an organization, which provided medical marijuana
to patients and was qualified under California's Compassionate Use Act
("CUA"), under the claim that their actions were in violation of the
CSA's prohibition of marijuana.14 The organization argued that its
distribution of medical marijuana was medically necessary.14 2 The Court
held that there is no medical necessity exception to the CSA and that the
Court could not infer such an exception because the legislature had
expressly classified marijuana as a Schedule I substance.14 3
In County of Santa Cruz v. Ashcroft," the plaintiffs also argued
that their use of medical marijuana was permissible under California's
CUA.14 5 Accordingly, the plaintiffs in this case sought a preliminary
injunction to enjoin the United States Attorney General and the DEA
from prosecuting those that use medical marijuana in compliance with
the CUA.1 46 The plaintiffs in this case put forth several claims, including
that the DEA was depriving them of their rights under the Fifth and
Ninth Amendments and that the application of the CSA to their activity
136.

See Medina, supra note 102, at 23 (contending that the FDA's current inability to approve

medical marijuana use has a negative impact and that if more leeway was granted by the
government for research or use, medical marijuana would be more accessible).
137. See Gonzales v. Raich, 545 U.S. 1, 9, 22, 25-26 (2005); United States v. Oakland
Cannabis Buyers' Coop., 532 U.S. 483, 491, 493-94 (2001); Assenberg v. Anacortes Hous. Auth.,
268 F. App'x 643, 644 (9th Cir. 2008); Cty. of Santa Cruz v. Ashcroft, 279 F. Supp. 2d 1192,
1203-05 (N.D. Cal. 2003).
138. See Gonzales, 545 U.S. at 27-29; Oakland CannabisBuyers' Coop., 532 U.S. at 490-91;
Cry. of Santa Cruz, 279 F. Supp. 2d at 1202-03, 1202 n.8.
139. See supra text accompanying notes 140-66.
140. 532 U.S. 483 (2001).
141. Id. at 486-87; see CAL. HEALTH & SAFETY CODE § 11362.5 (west 2007).
142. OaklandCannabisBuyers' Coop., 532 U.S. at 487, 490.
143. Id. at 490-93.
144. 279 F. Supp. 2d 1192 (N.D. Cal. 2003).
145. Id. at 1195-97.
146. Id. at 1195, 1198.
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"constitutes an unlawful exercise of Congressional powers under the
Commerce Clause." 14 7 The court held that, though it sympathized with
the patients and their undeniable pain, the DEA still maintains the right
to prosecute medical marijuana users in states where medical marijuana
is legal because the activity is contrary to the CSA and Congress has the
48
ability to regulate such activity under the Commerce Clause. 1 The
court also held that patients do not have a fundamental right to follow a
physician's recommendation to use medical marijuana. 149
Again in Gonzales v. Raich,"O respondents, who were California
residents as well as medical marijuana users and growers, claimed that
the CSA was applied unconstitutionally because their medical marijuana
use was authorized by the CUA.15 1 The Supreme Court held that the
enforcement of the CSA was valid because, under the Supremacy
Clause, federal law prevails over state law, even when the state is
attempting "to provide for the welfare or necessities of their
inhabitants." 2 This case ultimately demonstrates that if the federal
government decides to enforce the CSA, patients that utilize medical
marijuana are not protected by their state's medical marijuana laws due
to the supremacy of the CSA. 5 3
In Assenberg v. Anacortes Housing Authority,5 4 the Ninth Circuit
affirmed the lower court's holding that the plaintiff's use of
55
The
state-sanctioned medical marijuana was a violation of the CSA.
the
for
defense
necessity
medical
be
no
could
there
that
court explained
still
is
marijuana
medical
CSA,
use of marijuana and that, due to the
considered an illegal substance under the Fair Housing Act ("FHA") and
the Americans with Disabilities Act.' 56 As such, the court held that the
housing authority "did not have a duty to reasonably accommodate the
plaintiff's medical marijuana use."157
147. Id. at 1198, 1201, 1205.
148. Id. at 1203-05, 1208-09, 1212.
149. Id. at 1202-04.
150. 545 U.S. 1 (2005).
151. Id. at 6-7.
152. Id. at 29 (quoting Maryland v. Wirtz, 392 U.S. 183, 196 (1968)).
153. Id. at 29, 32-33; Kase & Shtern, supra note 11, at 4.
154. 268 F. App'x 643 (9th Cir. 2008).
155. Id. at 644; see Assenberg v. Anacortes Hous. Auth., No. C05-1836RSL, 2006 U.S. Dist.
LEXIS 34002, at *2-6 (W.D. Wash. May 25, 2006) (explaining that plaintiffs, who lived in an
apartment subsidized by the Department of Housing and Urban Development ("HUD"), were

utilizing and cultivating marijuana in their apartment in compliance with Washington State law but
in opposition to the CSA).
156. Assenberg, 268 F. App'x at 644; Assenberg, 2006 U.S. Dist. LEXIS 34002, at *13
(footnotes omitted) (explaining that, because marijuana is illegal under the CSA, plaintiff's
marijuana use "renders plaintiffs ineligible for federally subsidized housing pursuant to their lease,
HUD regulations, and federal statutes").

157. Assenberg, 268 F. App'x at 644.
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In Forest City Residential Management. v. Beasley,15 8 the
defendant requested that she be able to use medical marijuana in her
apartment as a reasonable accommodation under the FHA.1 59 She was a
participant in a federally-subsidized housing program and received
medical marijuana under Michigan's Medical Marihuana Act, but once
plaintiff discovered that the defendant was using marijuana in her
apartment, an eviction proceeding was brought claiming violation of the
signed leasing agreements. 1 0 The plaintiff claimed, among other things,
that the CSA preempted Michigan's Medical Marihuana Act, making
defendant's marijuana use illegal.16' The court held that the CSA
preempted Michigan's law and that the FHA does not require reasonable
accommodations for medical marijuana use as marijuana is an illegal
drug under the CSA.1 62
Most recently, in United States v. McIntosh,1 63 the Ninth Circuit
evaluated the impact of the provision of the 2016 Consolidated
Appropriations Act ("CAA") which states that the DOJ cannot spend
funds to prosecute individuals' "use, distribution, possession, or
cultivation of medical marijuana" in compliance with their state's law.'
The court held that the CAA "bars the federal government from
prosecuting someone who fully complies with the medical marijuana
laws in his state," despite the CSA's ban on marijuana.1 65 This is
because the DOJ would be "prevent[ing] the state from giving practical
effect to its law providing for non-prosecution of individuals who
engage in the permitted conduct."1 66 However, the court also reinforced
the notion that the DOJ is not prohibited from prosecuting "[i]ndividuals
who do not strictly comply" with their state's medical marijuana laws.' 67
Moreover, though the court maintains that the CSA is still valid law, the
court effectively upheld the constitutionality of the CAA's ban on the
prosecution of state-sanctioned medical marijuana users.1 68

158. 71 F. Supp. 3d 715 (E.D. Mich. 2014).
159. Id. at 719.
160. Id. at 720.
161. Id. at 726.
162. Id. at 727, 730-31.
163. 833 F.3d 1163 (9th Cir. 2016).
164. Consolidated Appropriations Act, 2016, Pub. L. No. 114-113, § 542, 129 Stat. 2242, 2333
(2015); McIntosh, 833 F.3d at 1174-76 (considering the argument that the DOJ violated the
Appropriations Clause of the Constitution when it spent funds to prosecute appellants for the growth
and distribution of medical marijuana, in compliance with state law, in violation of the Consolidated
Appropriations Act of 2016).
165. Paul J. Larkin, Jr., MarijuanaEdibles and "Gummy Bears," 66 BUFF. L. REV. 313, 357
(2018); see also McIntosh, 833 F.3d at 1178.
166. McIntosh, 833 F.3d at 1177.
167. Id. at 1178.
168. See id. at 1177-78, 1179 n.5.
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The foregoing cases have demonstrated that up until McIntosh, the
courts strictly held that the CSA preempted state law and that individuals
169
However, the
utilizing medical marijuana could be prosecuted.
the states
view,
Circuit's
Ninth
the
in
that
indicated
McIntosh
in
decision
by
CAA
the
in
found
protections
the
of
may now take advantage
170
Nevertheless,
implementing their own medical marijuana programs.
the CSA is still valid and preempts state law; therefore, medical
marijuana users and their caregivers must strictly adhere to state law, as
71
they otherwise could be prosecuted under the CSA.1
C.

The States' Position on Medical Marijuana

The states have taken an approach on medical marijuana that is
17 2
As of June
markedly different from that of the federal government.
2019, eleven states and Washington, D.C., have legalized the
recreational use of marijuana. 7 3 Though not all fifty states have
legalized marijuana, thirty-three states have passed legislation allowing
1 4
While each
for the use of medical marijuana in certain circumstances.
on the
focus
primarily
state has different requirements, this Note will
1 5
Florida is noteworthy because,
policies of Florida and New York.
besides having a comprehensive marijuana statute, it also has one of the
oldest populations in the country. 17 6 New York, on the other hand, has
added specific components to its marijuana regulations, which allow
77
facilities to act as caregivers for medical marijuana patients.1 This Note

169. See id. at 1178; Gonzales v. Raich, 545 U.S. 1, 29 (2005); United States v. Oakland
Cannabis Buyers' Coop., 532 U.S. 483, 490-91 (2001); Assenberg v. Anacortes Hous. Auth., 268 F.
App'x 643, 644 (9th Cir. 2008); Cty. of Santa Cruz v. Ashcroft, 279 F. Supp. 2d 1192, 1203 (N.D.
Cal. 2003).
170. See McIntosh, 833 F.3d at 1176-78.
171. See Gonzales, 545 U.S. at 26, 29; McIntosh, 833 F.3d at 1178.
172. See Hickner & Wilber, supra note 8, at 41-42; Groundbreaking, Comprehensive, Vital:
The National Nursing Guidelinesfor Medical Marijuana, NAT'L COUNCIL STATE BDS. NURSING

(Jan. 15, 2019), https://www.ncsbn.org/13331.htm.
173.

Berke & Gould, supra note 8; German Lopez, MarijuanaHas Been Legalized in 11 States

PM),
12:22
2019,
25,
VOX
(June
DC,
Washington,
and
https://www.vox.com/identities/201 8/8/20/1 7938336/marijuana-legalization-states-map (stating that
in 2012, Colorado and Washington State were the first states to legalize recreational marijuana).
174. Hickner & Wilber, supra note 8, at 41-42; Berke & Gould, supra note 8.
175. See infra Part II.C.1-2.
176. Press Release, U.S. Census Beureu, 65 and Older Population Grows Rapidly as Baby
6
Boomers Age (June 25, 2020), https://www.census.gov/newsroom/press-releases/2020/ 5-olderVirginia
West
Florida,
Maine,
in
people
population-grows.html (stating that in 2019, "one in five
and Vermont were age 65 or older. Maine had the largest share (21.2%) of population in that age
group, followed by Florida (20.9%), West Virginia (20.5%) and Vermont (20.0%)"); see FLA. STAT.
ANN. § 381.986 (West 2014).
177. N.Y. COMP. CODES R. & REGS. tit. 10,§ 1004.3(k) (2018).
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will examine the medical marijuana regulations of both states to provide
a general understanding of the states' responses to medical marijuana.178
1. Florida's Medical Marijuana Legalization Initiative
In 2014, Florida first introduced the state to medical marijuana
through its "Compassionate Use of Low-THC Cannabis" law, which
allowed certain patients, who otherwise had no alternative treatment
options available, access to medical marijuana.179 Thereafter, in 2016,
Florida formally legalized the medical use of marijuana for a broader
subset of residents. 180 This was accomplished by Florida voters when
they approved what is known as "Amendment 2," or the Florida Medical
Marijuana Legalization Initiative, which amended the State's
Constitution to permit patients with certain debilitating illnesses, such as
cancer, Parkinson's Disease, and epilepsy, to obtain medical
marijuana.1 81 However, at that time, the law restricted the form in which
medical marijuana could be used. 8 2 For instance, the scope was limited
by allowing only "oils, sprays, tinctures, edibles, and vaping," but
"deliberately exclud[ing]" smoking cannabis.8 3 Then, in March of 2019,
Florida expanded its legislation to legalize the use of medical marijuana
in a smokable form.1 84 Now, Florida is on track to become one of the
"top three states for the sale of cannabis products."1 85
178. See infra Part II.C.1-2.
179. Smith & Lannon, supra note 103, at 60 (explaining the "Compassionate Use of Low-THC
Cannabis" legislation). The Compassionate Medical Cannabis Act of 2014 created section 381.986
of the Florida Statutes and titled the section "Compassionate Use of Low-THC Cannabis," so

references to section 381.986 and the "Compassionate Use of Low-THC Cannabis" legislation are
one in the same.
180. Smith & Lannon, supra note 103, at 60; see § 381.986(2).
181. Smith & Lannon, supra note 103, at 60 ("[O]n November 8, 2016, the overwhelming
majority of Floridians (71.3 percent) approved Amendment 2, which expands the previously limited
Florida medical marijuana law."); see § 381.986; FLA. CONST. art. X, § 29; see also Frank Gluck,
Medical Marijuana Approved by Florida Voters, NEWS-PRESS (Nov. 8, 2016, 8:42 PM),
https://www.news-press.com/story/news/politics/2016/1 1/08/florida-medical-marijuana-leading-vot
es/93170144; Summary of Florida'sAmendment 2, MARIJUANA POL'Y PROJECT, https://www.mpp.

org/states/florida/amendment2 (last visited Nov. 7, 2020); Sara Brittany Somerset, Florida to
Announce Legalization of Medical Marijuana Flower, FORBES (Jan. 17, 2019, 12:04 PM),
https://www.forbes.com/sites/sarabrittanysomerset/2019/01/17/florida-to-announce-legalization-of-

medical-marijuana-flower.
182.

Somerset, supra note 181.

183. See id.
184. Michelle Lou & Brandon Griggs, Two Years After Voters Approved It, FloridaLegalizes
Smoking Marijuana,CNN: POLITICS (Mar. 19, 2019, 12:32 PM), https://www.cnn.com/2019/03/19/

politics/medical-marijuana-legal-florida-trnd.
185. Marcia Heroux Pounds, FloridaIs Becoming a Leader in Nation's MarijuanaMovement,
S. FLA. SUN SENTINEL (Nov. 1, 2019, 6:30 AM), https://www.sun-sentinel.com/business/fl-bz-

cannabis-store-growth-20191101-bc4befu7fjatjncqtz2tsosici-story.html (explaining that the lack of
competition for dispensaries, the legalization of smokable medical marijuana products, and an
increase in qualified medical marijuana users are responsible for Florida's increased sales of
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Currently, Florida maintains a comprehensive statute that legalizes
the medical use of marijuana. 18 6 This statute has several noteworthy
portions, including a section that precisely defines what conditions
qualify a person to use medical marijuana,187 as well as a section that
88
places restrictions on who may qualify to be a patient's "caregiver."'
The statute provides that, in order to be eligible for legal use of medical
marijuana, a patient must, among other things, be diagnosed with at least
one of the following qualifying medical conditions:
(a) Cancer. (b) Epilepsy. (c) Glaucoma. (d) Positive status for human
immunodeficiency virus. (e) Acquired immune deficiency syndrome.
(f) Posttraumatic stress disorder. (g) Amyotrophic lateral sclerosis. (h)
Crohn's disease. (i) Parkinson's disease. (j) Multiple sclerosis. (k)
Medical conditions of the same kind or class as or comparable to those
189
diagnosed
enumerated in paragraphs (a)-(j). (1) A terminal condition
by a physician other than the qualified physician issuing the physician
190
certification. (m) Chronic nonmalignant pain.

This Florida restriction on which medical conditions qualify a patient to
use medical marijuana is notable because some states allow doctors to
recommend marijuana for patients they deem to have "debilitating
medical condition[s]" instead of restricting them to conditions
191
enumerated in a statute.
Additionally, Florida imposes several requirements that limit who
may serve as a patient's caregiver for the purpose of managing a
patient's medical marijuana use.9' The foremost requirement is that a
caregiver must be a minimum of twenty-one years old and must become

marijuana products).
186. See § 381.986(1)() ("'Medical use' means the acquisition, possession, use, delivery,
transfer, or administration of marijuana authorized by a physician certification."); FLA. CONST.
art. X, § 29 ("Medical marijuana production, possession and use.").
187. See § 381.986(2).
188. See § 381.986(1)(a) ("'Caregiver' means a resident of this state who has agreed to assist
with a qualified patient's medical use of marijuana, has a caregiver identification card, and meets
the requirements of subsection (6).").
189. § 381.986(1)(o) ("'Terminal condition' means a progressive disease or medical or surgical
condition that causes significant functional impairment, is not considered by a treating physician to
be reversible without the administration of life-sustaining procedures, and will result in death within
1 year after diagnosis if the condition runs its normal course.").

190. § 381.986(2).
191. Marks, supra note 59, at 137 ("Physicians in Massachusetts can prescribe marijuana for
any 'debilitating medical condition.' The statute provides examples of debilitating conditions while
leaving the term open to interpretation by physicians. Thus, many medical conditions can qualify.
Still, other states such as Connecticut and Florida take a more restrictive approach. They limit
medical marijuana to patients with specific conditions, and physicians have little discretion to
determine whether a condition qualifies for treatment.").
192. § 381.986(1)(a), (6); FLA. CONST. art. X, § 29(b)(7).

https://scholarlycommons.law.hofstra.edu/hlr/vol49/iss1/11

22

Vaiana: Give Grandma Her Ganja: Exploring the Need for an Exception to th

GIVE GRANDMA HER GANJA

2020]1

297

qualified by the state. 193 Furthermore, the Florida statute stipulates that a
patient may generally only designate "one caregiver to assist with the
qualified patient's medical use of marijuana." 94 However, there are
exceptions that allow children under eighteen and certain disabled adults
to have more than one parent or guardian serve as caregivers and an
exception that allows patients in hospice programs to have multiple
caregivers.' 95
The statute also provides for a unique exception for patients
"participating in a research program in a teaching nursing home pursuant
to [section] 1004.4351."196 Under state law, a designated Medical
Marijuana Research Board 197 has the ability to "award funds to teaching
nursing homes, as defined in [section] 430.08, for research on medical
use of marijuana to alleviate conditions related to chronic disease and
aging."1 98 Therefore, this program allows for the elderly to have direct
access to medical marijuana while residing in approved nursing
homes. 199 However, there is currently only one such state-sanctioned
teaching nursing home, MorseLife Health System ("MorseLife").2 00
MorseLife provides over 3,600 seniors with "assisted living, short
term rehabilitation, long term care, memory care and hospice"
services. 2 0' Though this program is primarily intended for research
purposes, MorseLife is now able to provide its elderly clients with
medical marijuana to address pain, along with education on the benefits
of marijuana for medical treatment, and to "reduce the reliance on
pharmaceuticals and opioids." 202 Nevertheless, despite state approval of
193. § 381.986(6)(a), (b)(2); FLA. CONST. art. X, § 29(bX7).
194. § 381.986(6)(c).
195. Id. § 381.986(6)(c)(1)-(3).
196. Id. § 381.986(6)(c)(4); see FLA. STAT.
"teaching nursing home," see FLA. STAT.

§

1004.4351(4)(d) (2019). For the definition of

§ 430.80(1)

(2019) ("[T]he term 'teaching nursing home'

means a nursing home facility licensed under chapter 400 which contains a minimum of 170
licensed nursing home beds; has access to a resident senior population of sufficient size to support
education, training, and research relating to geriatric care; and has a contractual relationship with a
federally funded accredited geriatric research center in this state or operates in its own right a
geriatric research center.").

197. See § 1004.4351(4) (outlining the procedure for establishing a Medical Marijuana
Research Board, "composed of members representing each participating university" that is
approved to conduct research on medical marijuana in the state).
198. § 1004.4351(4)(d).
199. See §430.80.
200.

Andrew Felix, MorseLife Receives Approval to Offer CBD Therapiesfor Elder Care,

MIA. CMTY. NEWSPAPERS (Oct. 23, 2019), https://communitynewspapers.com/cannabis/morselifereceives-approval-to-offer-cbd-therapies-for-elder-care;

Industry Leader MorseLife Receives State

Approval to Offer Medical Marijuana Therapiesfor Elder Care, BUS. wIRE (Apr. 23, 2019, 11:08
AM), https://www.businesswire.com/news/home/20190423005701/en/Industry-Leader-MorseLifeReceives-State-Approval-Offer [hereinafter Industry LeaderMorseLife].
201. Industry Leader MorseLife, supra note 200.
202. Felix, supra note 200.
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this program,203 and its potential to generate a host of positive
outcomes, 2 4 MorseLife may not use any "federal funds .. . to pay for
the resources associated with medical marijuana treatment. "205
Moreover, in recent years, the state of Florida has become a leader
206
The state constitution and
in the realm of medical marijuana.
comprehensive legislation make marijuana accessible for many
residents. 2 07 Additionally, Florida's willingness to participate in medical
marijuana research has allowed a portion of the elderly population
208
residing in nursing homes to benefit from medical marijuana.
However, due to the CSA and state limitations on qualifying medical
conditions, there is still a need for federal legislation to make medical
marijuana accessible to the broader population of nursing home and
209
assisted living facility residents.
2. New York's Compassionate Care Act
In 2014, New York passed what is known as the Compassionate
Care Act ("CCA"). 21 0 The CCA allows for patients with certain "serious
conditions" to become designated as a "certified patient" in order to
obtain medical marijuana. 211 Similar to other states' medical marijuana
provisions, New York defines having a "serious condition" sufficient to
qualify for medical marijuana as:
(i) having one of the following severe debilitating or life-threatening
conditions: cancer, positive status for human immunodeficiency virus
or acquired immune deficiency syndrome, amyotrophic lateral
sclerosis, Parkinson's disease, multiple sclerosis, damage to the
nervous tissue of the spinal cord with objective neurological indication
of intractable spasticity, epilepsy, inflammatory bowel disease,
neuropathies, Huntington's disease, post-traumatic stress disorder, pain
that degrades health and functional capability where the use of medical
marihuana is an alternative to opioid use, substance use disorder, or as

203.
204.

See supra note 196 and accompanying text.
Industry Leader MorseLife, supra note 200 (stating that "[t]he study has the potential to

revolutionize treatment protocols for multiple illnesses affecting senior citizens by using
cannabinoids to reduce the side-effects, addiction rate, and cost of standard medical protocols using
opioids.").
205. Felix, supra note 200.
206.

207.
208.
209.
210.
(Consol.
211.

See supranote 175 and accompanying text.

See supra notes 176-90 and accompanying text.
See supra notes 196-99 and accompanying text.
See infra Part III.
Beach & Appleby, supra note 16, at 45; see N.Y. PUB. HEALTH LAW
2014).
PuB. HEALTH

§ 3360

§§ 3360-3369.

("'Certified patient' means a patient who is a resident of New York

state or receiving care and treatment in New York state as determined by the commissioner in
regulation, and is certified under [section 3361]."); see PUB. HEALTH § 3361.
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added by the commissioner; and
(ii) any of the following conditions where it is clinically associated
with, or a complication of, a condition under this paragraph or its
treatment: cachexia or wasting syndrome; severe or chronic pain;
severe nausea; seizures; severe or persistent muscle spasms; or such
conditions as are added by the commissioner. 212

Much of the CCA is comparable to other states' medical marijuana
legislation. 213 However, since the passing of the CCA, New York has
implemented several emergency regulations to expand upon the bill. 2 4
What makes New York's law noteworthy is that, on October 5, 2017,
New York State amended its medical marijuana regulations by
emergency regulation to permit a "facility" to register as a "designated
caregiver" in order to better accommodate the needs of residents of
nursing homes, group homes, and other skilled nursing facilities. 215
Most commonly, a person's caregiver is a family member. 2 16
However, in New York, if a nursing home resident becomes a certified
patient under state law, the nursing home itself may register to serve as
that resident's designated caregiver. 2 17 This allows for the nursing home,
or more specifically, its designated staff members, to obtain and store
the marijuana on behalf of the resident. 218 It also permits the staff
members to dispense the marijuana directly to the patient. 2 19 Usually,
under New York law, one caregiver may only be designated for up to
five certified patients. 220 Consequently, to avoid this from preventing
212. PUB. HEALTH § 3360(7)(a).
213. Compare PUB. HEALTH §§ 3360-3369 (outlining New York's Compassionate Care Act),
with CAL. HEALTH & SAFETY CODE § 11362.7 (West 2007) (defining California's medical

§ 29

marijuana provisions), and FLA. CONST. art. X,

provisions in 2016), and TEx. Occ. CODE ANN.

§

(adopting Florida's medical marijuana

169 (West 2015) (defining Texas's medical

marijuana provisions).

214. See

Joseph

Rosado,

NY

Marijuana

Qualification

https://www.marijuanadoctors.com/medical-marijuana/ny/qualification

(Aug.

8,

(discussing

2019),
recent

legislative updates and expansions of the Compassionate Care Act).
215. veronique Urban, Medical Marijuana Update - "Caregiver" Definition Expanded to
Include
Facilities,
FARRELLFRITZ
(Oct.
31,
2017),
https://www.nyhealthlawblog.com/2017/10/3 l/medical-marijuana-update-caregiver-defmition-

expanded-to-include-facilities; see N.Y. COMP. CODES R. & REGS. tit. 10, § 1004.3(k) (2018).
216. Jason A. Frank & Melissa Baum, Global Analysis: Social Insurance to Pay for
Long-Term Care, MD. B.J., Mar.-Apr. 2008, at 26, 28.
217. Tit. 10, § 1004.3(k).
218. See PUB. HEALTH § 3360(1) (allowing the "acquisition, possession, delivery,
transportation or administration" of medical marijuana by designated caregivers, which includes

facilities or natural persons selected by a certified patient, tit. 10, § 1004.3(k)).
219. Tit. 10, § 1004.23(c) ("Designated caregivers, including employees of facilities registered
as designated caregivers and acting within their scope of employment, shall not be subject to arrest,
prosecution, or penalty in any manner . . solely for an action or conduct in accordance with [Title
10, Part 1004].").
220. Id. § 1004.23(a).
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nursing homes and other skilled nursing facilities from managing
multiple residents' medical marijuana, the law considers "each division,
department, component, floor or other unit of such facility .. . to be a
'facility."' 221 As a result, "each division, department, component, [or]
floor" of a nursing home is able to manage up to five residents' medical
22
marijuana.2
While New York's medical marijuana regulations appear to be
favorable to nursing home residents, many nursing homes and assisted
living providers in the state are still hesitant to allow medical marijuana
on their premises. 223 The state may not mandate that a facility become a
designated caregiver; thus many facilities exercise their discretion in
2 24
Even though New York law allows facilities
opting not to participate.
cannot protect nursing homes and assisted
laws
to act as caregivers, the
living facilities from liability under the CSA, and since "there is a risk of
losing Medicare and Medicaid reimbursement, such institutions may not
want to encourage their employees to violate federal law,
2 5
As a result, there
notwithstanding the low likelihood of prosecution."
be greater access
to
is
there
if
law
federal
in
a
change
for
is still a need
226
State.
York
New
in
to medical marijuana
LACK OF ACCESS TO MEDICAL MARIJUANA IN NURSING HOMES:
WHY NURSING HOMES ARE AFRAID TO PARTICIPATE IN
STATE-SANCTIONED MEDICAL MARIJUANA PROGRAMS

III.

It is a commonly held belief that medical marijuana is a particularly
helpful treatment for elderly Americans experiencing an array of health
221. Id. § 1004(k).
A designated caregiver may be either a natural person or a facility. For purposes of this
section, a "facility" shall mean: a general hospital or residential health care facility
operating pursuant to Article 28 of the Public Health Law; an adult care facility
operating pursuant to Title 2 of Article 7 of the Social Services Law; a community
mental health residence established pursuant to section 41.44 of the Mental Hygiene
Law; a hospital operating pursuant to section 7.17 of the Mental Hygiene Law; a mental

hygiene facility operating pursuant to Article 31 of the Mental Hygiene Law; an
inpatient or residential treatment program certified pursuant to Article 32 of the Mental

Hygiene Law; a residential facility for the care and treatment of persons with
developmental disabilities operating pursuant to Article 16 of the Mental Hygiene Law;
a residential treatment facility for children and youth operating pursuant to Article 31 of

the Mental Hygiene Law; or a private or public school. Further, within each of the
facilities listed above, each division, department, component, floor or other unit of such
facility shall be entitled to be considered to be a facility for purposes of this section.
Id.
222.
223.
224.
225.
226.

Id. § 1004.23(a).
See Kase & Shtern, supra note 11, at 11-12.
See id. at 11.
Id.; see infra Part III.B.
Kase & Shtem, supra note 11, at 11-13.
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conditions. 227 However, many seniors are denied access to medical
marijuana, which they would otherwise be entitled to under state law,
because they reside in nursing homes, assisted living communities, and
other skilled nursing facilities. 228 This Part will address the issue of
medical marijuana usage by elderly Americans. 2 29 Subpart A will
discuss America's aging population and the increasing demand for
access to medical marijuana in nursing homes and other skilled nursing
facilities.2 30 Subpart B will address the barriers that make medical
marijuana difficult to obtain and how those barriers affect elderly
patients residing in nursing homes and skilled nursing facilities. 23 1
A.

The Needfor Access to Medical Marijuanain Nursing Homes and
Skilled NursingFacilities

As of 2015, the Centers for Disease Control and Prevention
recognized that there were 1.3 million residents living in nursing homes
in the United States. 232 Since then, the number of nursing home residents
has grown. 233 This is likely because the United States' elderly population
is growing at an increasing rate overall. 234 By the year 2034, simply due
to "[t]he aging of baby boomers[,] . .. older people are projected to
outnumber children for the first time in U.S. history." 235 As a result, it is
projected that there will be "more than a [fifty] percent increase in the
number of Americans ages [sixty-five] and older requiring nursing home
care, to about 1.9 million in 2030 from 1.2 million in 2017."236
Accordingly, as the population ages, more people will have to rely
on nursing homes and other skilled nursing facilities to meet their daily
227. See infra Part III.A.
228. See infra Part III.B.
229. See infra Part III.A-B.
230. See infra Part III.A.
231. See infra Part IIIB.
232. Nursing Home Care, CDC (May 20, 2020), https://www.cdc.gov/nchs/fastats/nursinghome-care.htm.
233.

See Elaine K. Howley, Nursing Home Facts and Statistics, U.S. NEWS (Oct. 11, 2019,

9:53 AM), https://health.usnews.com/health-news/best-nursing-homes/articles/nursing-home-factsand-statistics (estimating that as of 2019, "[t]here [was] about 1.4 to 1.5 million people living in
nursing homes").
234. Levinson, supra note 12, at 223; Press Release, U.S. Census Bureau, Older People
Projected
to
Outnumber
Children
for
First
Time
in
U.S.
History,
https://www.census.gov/newsroom/press-releases/2018/cbl8-41-population-projections.html
(Oct.
8, 2019).
235. Press Release, U.S. Census Bureau, supra note 234 (quoting Jonathan Vespa, a U.S.
Census Bureau demographer) ("By 2034 (previously 2035) there will be 77.0 million (previously
78.0) people 65 years and older compared to 76.5 million (previously 76.7 million) under the age of
18.").
236.

Mark Mather et al., Fact Sheet: Aging in the United States, POPULATION REFERENCE

BUREAU (July 15, 2019), https://www.prb.org/aging-unitedstates-fact-sheet.

Published by Scholarly Commons at Hofstra Law, 2020

27

Hofstra Law Review, Vol. 49, Iss. 1 [2020], Art. 11

302

HOFSTRA LAW REVIEW

[Vol. 49:275

needs. 237 With age, many people experience an array of illnesses that
require advanced care, and there are a multitude of reasons why
Americans decide to reside in nursing homes and assisted living
communities.238 For instance, some nursing home residents need
long-term assistance with mobility, feeding, bathing, or medication
management, while others only need short-term assistance while
239
Furthermore, there
recovering from a "surgical procedure or injury."
are many seniors that suffer from health conditions which cause them to
require assistance with daily tasks, most notably medication
management, but do not require the high level of care that nursing
homes provide. 240 These types of individuals are increasingly choosing
to reside in assisted living communities so they can receive daily care
while still maintaining more personal autonomy than they would in a
nursing home. 24 1
Regardless of their reasons for admission, most "[r]esidents in
nursing homes typically have at least one chronic condition for which
242
Some of the chronic health
they need some ongoing medical care."
conditions from which nursing home and assisted living residents
commonly suffer include "diabetes, arthritis, eye diseases [and]
2 43
as
cognitive impairments," such as Alzheimer's disease and dementia,
well as cancer, seizure disorders, "chronic pain, neuropathy, and
Parkinson's disease."244 Auspiciously, the health conditions that
commonly affect the elderly population are conditions that are included
245
in many states' medical marijuana statutes. Therefore, given the recent
increase in states that have legalized medical marijuana, more elderly

237. Levinson, supra note 12, at 223; CMS Review of Current Standards of Practice for
2004),
30,
(Dec.
1
GRP.
LEWIN
Services,
Pharmacy
Care
Long-Term

https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Reports/
downloads/lewingroup.pdf.
238. Howley, supra note 233.
239. Id. (contending that in 2015-2016, the most recent year where data is available, "16.5% of
[nursing home] residents were younger than age 65" and some younger residents were those with

developmental disabilities or people with short-term rehabilitative needs).
240. Tara A. Cope & Joel S. Goldman, Sex, Drugs and Rock 'n Chairs, 2010 AM. HEALTH
LAWS. ASS'N SEMINAR PAPERS, no. 1, 2010, at 1, 12, WL 20100217.

241. See id.
242. Howley, supra note 233.
243. Id.; see Zachary J. Palace & Daniel A. Reingold, Medical Cannabisin the Skilled Nursing
Facility: A Novel Approach to Improving Symptom Management and Quality of Life, 20 J. AM.
MED. DIR. ASS'N 94, 95 (2019).

&

244. Palace & Reingold, supranote 243, at 95.
245. See id.; see also N.Y. PUB. HEALTH LAW §§ 3360-3369 (Consol. 2014); CAL. HEALTH
SAFETY CODE § 11362.7 (West 2007); FLA. STAT. ANN. § 381.986(2) (West 2014); TEX. Occ.
CODE ANN. § 169.003 (West 2015).
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people are likely to seek medical marijuana as a part of their medical
treatment.24 6
Though research on the effects of medical marijuana use
specifically among seniors is limited as a result of the federal prohibition
on medical marijuana,247 thus far, elderly patients appear to be
experiencing success with medical marijuana treatments.248 Patients with
conditions like neuropathy, Parkinson's disease, cancer, and seizure
disorders have benefited the most from medical marijuana treatment,
regardless of age. 249 Additionally, according to the available research, it
appears that medical marijuana is extremely advantageous for pain
management in elderly patients.250 In fact, in a recent study, thirty-two
percent of elderly participants who utilized medical marijuana were able
to "reduce[] their opioid pain medication." 2 1 There has also been
encouraging feedback resulting from medical marijuana treatment of
seizure disorders and symptoms of rigidity associated with Parkinson's
disease in nursing home residents.25 2 Being that there is a large
population of Americans residing in nursing homes, many of whom are
suffering from health conditions that may benefit from the use of
medical marijuana, there is an increasing need for access to medical
marijuana in these facilities. 2 3
B.

Barriersto Accessing Medical Marijuanafor NursingHome and
Skilled Nursing FacilityResidents

Though it has been established that medical marijuana may now be
a viable treatment option for many health conditions, there are several
barriers that prevent nursing home residents from gaining access to it.2 54

246.

See Kase & Shtern, supra note 11, at 11; Judy George, Medical Marijuana and Older
MEDPAGE
TODAY
(Feb.
28,
2019),
https://www.medpagetoday.com/meetingcoverage/aan/78289 ("In the U.S., people age [sixty-five]
and older are among the fastest-growing group of cannabis users.").
247. See Vanessa Milne et al., Is Marijuana and Seniors a Bad Combination?, HEALTHY
DEBATE (June 29, 2017), https://healthydebate.ca/2017/06/topic/marijuana-seniors.

Adults,

248.

Palace & Reingold, supra note 243, at 97; George, supra note 246 (reporting on results

from a recent study, which found that "[a]dults who were an average age of [eighty-one]

experienced relief in chronic pain, sleep, neuropathy, and anxiety with medical cannabis").
249. See Palace & Reingold, supra note 243, at 95, 97; Shu-Acquaye, supra note 30, at 729.
250. See Palace & Reingold, supra note 243, at 97; George, supra note 246.
251.

George, supra note 246. One facility stated that "[m]ost residents receiving cannabis for

pain have commented on sustained improvement in chronic pain severity, resulting in reductions of
opioid dosage and an improved sense of well-being." Palace & Reingold, supra note 243, at 97.
252. See Palace & Reingold, supra note 243, at 97.
253. See supra notes 232-46 and accompanying text.
254.

See infra text accompanying notes 255-82.
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Many of these issues stem from the fact that medical marijuana is still
banned under the CSA. 5
For many patients, including those residing in New York, one of
the first hurdles to jump is becoming a "certified" or "qualifying"
256
patient, which allows for medical marijuana use under state law.
Practitioners who wish to declare patients as certified or qualified must
become registered with the state. 257 However, many doctors may be
2 58
Though doctors are
hesitant to become registered to certify patients.
advantages and
the
about
patients
their
to
speak
to
permitted
not actually
may
doctors
marijuana,
medical
disadvantages of using
25 9
were to
doctor
If
a
prescribe it without facing criminal penalty.
prescribe marijuana, she would be in violation of the CSA and could
face criminal prosecution and lose her ability to receive insurance
2
reimbursements under Medicaid or Medicare. 1 The doctor would also
risk losing her ability to register with the DEA, which gives her the
ability to prescribe controlled substances, because the DEA does not
2 61
permit Schedule I drugs to be prescribed. Thus, it is more likely that
doctors will merely discuss marijuana use with their patients without
taking on the burden of becoming a certifying doctor and prescriber of
the medical marijuana. 262 This creates frustrations for patients who may
2 63
have limited mobility or live far from a certifying doctor.
255. See supra Part II.B.1; Controlled Substances Act, 21 U.S.C. § 812(c) (Schedule I(c)(10)).
256. See N.Y. PUB. HEALTH LAW § 3360(3), (7)(a) (Consol. 2014); CAL. HEALTH & SAFETY
CODE § 11362.7(f), (h) (West 2007); FLA. STAT. ANN. § 381.986(l1), (2) (West 2014); FLA.
CONST. art. X, § 29; TEX. Occ. CODE ANN. § 169.003 (West 2015); N.Y. COMP. CODES R. & REGS.
tit. 10, § 1004.3 (2018) (explaining the process for becoming a certified patient in New York).
257. See PUB. HEALTH § 3360(12).
258.

See Symposium, The Criminalization of Medicinal Marijuana, 11 HASTINGS WOMEN'S

L.J. 75, 88, 101 (2000) (explaining that there is a gray area between aiding and abetting patients in
breaking the federal law and lawfully providing them with medical marijuana).
259. See id.; Conant v. Walters, 309 F.3d 629, 635-39 (9th Cir. 2002) (holding that doctors
have a First Amendment right to recommend medical marijuana to patients and cannot be punished
for recommending such use; however, doctors may not prescribe marijuana without potentially
"be[ing] guilty of aiding and abetting [in] violation of federal law."); Gibbons, supra note 31, at 3
("[I]t is generally viewed that physicians can discuss and recommend marijuana to patients without
running afoul of federal law.").

260. See Kase & Shtern, supra note 11, at 11 (explaining that nursing home and health care
institutions' Medicaid and Medicare reimbursements could be jeopardized by any involvement with
medical marijuana, as their behavior may qualify as aiding and abetting a patient in violation of
federal law); Hickner & Wilber, supra note 8, at 44; Ryan Marcus, Medicare, Medicaid, and
Medical Marijuana: Why Hospitals Should Not Be High on Patient Certification, 24 ANNALS
HEALTH L. & SCIS.: ADVANCE DIRECTIVE 1, 6-7 (2014).

261. Marcus, supra note 260, at 9; Michael Gabay, The Federal ControlledSubstances Act: A
Primerfor Providers, PRAC. PAIN MGMT., https://www.practicalpainmanagement.com/resources/pr
actice-management/federal-controlled-substances-act-primer-providers (Nov. 20, 2019) (describing
DEA registration).
262. See Symposium, supra note 258, at 88.
263.

Take Care Staff, New York's Medical MarijuanaProgram Grows, Tackles New Problems,
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Additionally, some medical professionals are hesitant to encourage
the use of medical marijuana at all. 2" Among the doctors' concerns are
the potential side effects of marijuana, as well as the possibility of
unknown interactions between the medications that many elderly
individuals take and marijuana. 26 Some doctors fear that marijuana may
cause side effects or drug interactions, including dizziness, which could
increase the chances of an elderly person falling down and injuring
themselves. 266 Nevertheless, some researchers and doctors argue that the
benefits of medical marijuana outweigh the potential side effects and
that elderly patients can be monitored for any potential drug
interactions.2 67 Furthermore, even though some patients report
experiencing adverse side effects from marijuana, it is reported that upon
altering marijuana dosages, patients often experience little to no side
effects.2 68
Once a patient finds a doctor willing to certify them, the next
obstacle lies in physically obtaining the medical marijuana. 269 Similar to
the impediments that doctors face, pharmacists and pharmacies may not
fill a prescription for medical marijuana due to its illegality under the
CSA. 27' Instead, in many states, patients must obtain their medical
marijuana from state-approved dispensaries. 27 1 Some states place a limit
on the number of dispensaries available in its jurisdiction for patients to
utilize.2 7 2 This is an additional burden, especially for patients who reside
wRvo PUB. MEDIA (May 25, 2019), https://www.wrvo.org/post/new-yorks-medical-marijuanaprogram-grows-tackles-new-problems (noting that finding a doctor is still an issue, though
telemedicine has improved access for some).
264. See Gregorio, supra note 81.
265. See Abbie Rosner, Adding Cannabis to the Mix: Risks and Benefits for Seniors, FORBES
(Feb. 5, 2019, 6:29 AM), https://www.forbes.com/sites/abbierosner/2019/02/05/adding-cannabis-tothe-mix-risks-and-benefits-for-seniors; Dennis Thompson, Medical Marijuana Helped Elderly with
Chronic Pain and Reduced Their Use of Opioids, Study Found, CHI. TRIB. (Mar. 11, 2019, 8:30
AM),
https://www.chicagotribune.com/lifestyles/health/sc-hlth-medical-marijuana-elderly-painrelief-0320-story.html.
266.

See Milne et al., supranote 247; Rosner, supra note 265.

267. See Milne et al., supra note 247; Rosner, supra note 265 (recounting that while one doctor
acknowledges that there are some risks for seniors using medical marijuana, he is "much more

excited about the beneficial drug interactions and harm-reduction substitutions with medical
cannabis").
268. See Milne et al., supra note 247 (explaining that one doctor "start[s] seniors on a lower
dose [of marijuana] than she uses for other people" in order to best determine the proper dose for

her senior patients and avoid side effects); Thompson, supra note 265 (reporting that common side
effects including "sleepiness .. .balance problems ... and gastrointestinal issues" dissipated for
thirteen percent of patients after changes in dosing).
269. See Take Care Staff, supra note 263 (discussing the limited number of dispensaries
throughout the country).
270. Brown, supra note 41, at 1537-39.
271. See FLA. CONST. art. X, § 29(b)(5), (d)(1)(c); N.Y. PUB. HEALTH LAW § 3364 (Consol.
2014); Brown, supra note 41, at 1549, 1557 (highlighting dispensary protocol in New Jersey).
272. See FLA. STAT. ANN. § 381.986(8)(5) (West 2014); Brown, supra note 41, at 1549; Take
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in more rural areas, who are less likely to be in close proximity to a
dispensary. 273
In addition, cost remains a significant barrier to seniors' access to
medical marijuana. 274 As discussed in Part II, marijuana's scheduling as
a Schedule I substance prevents insurance companies from covering the
cost of medical marijuana. 275 Marijuana's status as a Schedule I
substance also allows health insurance providers to deny coverage for a
doctor's visit if the purpose was to gain authorization for medical
marijuana use. 276 The cost of the medical marijuana treatments and
doctors' appointments can be prohibitive for some patients.27 For
instance, in New Mexico, a marijuana evaluation with a state-sanctioned
doctor may cost "US$135 to US$170 for a single evaluation, and
US$300 for two evaluations." 2 78 The high out-of-pocket costs prevent
some elderly people from participating in the sanctioned medical
279
marijuana programs, even when they are eligible to do so.
The final barrier to receiving medical marijuana applies specifically
to seniors who would like to utilize medical marijuana in nursing homes,
280
It is
assisted living communities, and other skilled nursing facilities.
important to note that some nursing homes and skilled nursing facilities
do allow the use of medical marijuana. 281 However, states do not
mandate that assisted living facilities or nursing homes allow medical
2 82
marijuana in their facilities, even if it is legal in the state.
Care Staff, supra note 263.
273. See Take Care Staff, supra note 263; see also Symposium, supra note 258, at 96 (arguing
that marijuana should be rescheduled, which would allow doctors to write prescriptions, and
pharmacies to fill those prescriptions, thereby increasing the ease in which patients could obtain
medical marijuana).
274. See Medina, supra note 102, at 23; Palace & Reingold, supra note 243, at 97; Reid, supra
note 30, at 199.
275. See supra Part II.B.4; Kase & Shtern, supra note 11, at 10, 12 (explaining that it is not
required that medical marijuana be covered by Medicaid or other health insurance).
276. Medina, supra note 102, at 23 (explaining that under some plans, if the visit is solely for
the purpose of obtaining medical marijuana, the insurance provider may deny coverage).
277. See Collins, supra note 117.
278. Reid, supra note 30, at 199.
279. Palace & Reingold, supra note 243, at 97.
280. See Beach & Appleby, supra note 16, at 47.
281. See id.
Maine permits nursing homes and inpatient hospice workers to act as registered "medical

marijuana" caregivers for patients; Michigan, Oregon, and Rhode Island include
"agitation of Alzheimer's'D' [sic] as a qualifying condition for legal use of medical
marijuana; Montana does not permit smoking in any health care facility, but cannabis

may be used in other forms; and New Mexico allows medical marijuana use in skilled
nursing facilities.
Id.
282.

See Joanne R. Lax & Cynthia F. Wisner, In the Crosshairs: The Intersection of

Management Prerogative and Resident Demand in Assisted Living Facilities, Skilled Nursing
Facilitiesand Home and Community Based Service Programs, 2010 AM. HEALTH LAWS. ASS'N
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Consequently, many facilities do not allow medical marijuana on their
premises because they are concerned that it will jeopardize their federal
funding, most commonly from Medicaid, Medicare, or the Department
of Veterans Affairs. 283
Medicaid and Medicare are especially important to nursing home
providers and their residents. 284 Medicare is sometimes used by the
elderly to pay for short-term "medically necessary skilled nursing"
services. 28 5 However, the bulk of nursing home funding comes from
Medicaid. 286 In fact, Medicaid funding currently "pays for the costs of
two-thirds of all nursing home residents." 287 Having policies that permit
the use of medical marijuana becomes problematic for nursing homes
because "billing for services under Medicare or Medicaid includes a
provision of certifying compliance with all federal and state law." 288
Being that marijuana is banned under federal law, some facilities are
hesitant to allow their staff to manage patients' medical marijuana, as the
facility could be held in violation of the federal law.2 89
Some nursing homes and assisted living facilities have developed
policies that act as loopholes in allowing them to permit medical
marijuana use while evading criminal liability and punishment. 2 90
Typically, both nursing homes 291 and assisted living facilities manage
residents' medications, 292 primarily in order to safeguard residents from
accidentally mismanaging them. 293 However, in order to provide their
SEMINAR PAPERS, no. 1, 2010, at 1, 11-12, wL 20100217.
283. See Kase & Shtern, supra note 11, at 11; Marcus, supra note 260, at 7 (explaining that

Medicaid and Medicare may view medical marijuana certification as being in violation of federal
law); Jessica Portner, Federal Law Complicates Medical Marijuana Use in Nursing Homes, CAL.
HEALTH REP. (June 2, 2017), https://www.calhealthreport.org/2017/06/02/federal-law-complicatesmedical-marijuana-use-nursing-homes; Claire Hansen, Veterans FaceHurdles to MarijuanaAccess

(May 27, 2019, 6:00 AM), https://www.usnews.com/news/health-news/articles/2019-0527/veterans-face-hurdles-to-accessing-medical-marijuana;
Ryan Parker,
Medical-Marijuana
Policies in Colorado Nursing Homes Are Cloudy, DENVER POST (Apr. 30, 2016, 8:59 PM),
https://www.denverpost.com/2012/05/01/medical-marijuana-policies-in-colorado-nursing-homesare-cloudy (explaining that one facility chose not to permit medical marijuana use for liability
reasons because "[t]he marijuana would have to be administered by nurses").
284. See Levinson, supra note 12, at 224.
285. Id. Medicare is "primarily a government health insurance program for individuals over the
age of sixty-five." Id.

286. See id. (describing Medicaid as the largest health care provider, serving "[a]pproximately
fifty-three million needy individuals, including low-income pregnant women, children, children's
caregivers, disabled individuals, and senior citizens").
287. Levinson, supra note 12, at 224; see also Howley, supra note 233 (noting that, at this
time, "Medicaid pays for the majority of nursing home care in this country").

288.
289.
290.
291.
292.

Marcus, supra note 260, at 7.
See supra note 225 and accompanying text.
See infra notes 291-300 and accompanying text.
See Howley, supranote 233.
See Cope & Goldman, supra note 240, at 12.

293.

See id.; see also CMS Review of Current Standards of Practicefor Long-Term Care
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residents with access to medical marijuana, some facilities now allow
residents to utilize marijuana on their premises, so long as the resident
2 94
purchase and self-administers his or her medical marijuana. While this
type of policy seems appealing because it allows elderly residents who
29
are suffering to access treatment involving medical marijuana,
2 96
self-administration of medications, in general, is not always advisable.
Some seniors lack the ability to self-administer medications because of
physical and cognitive health issues. 297 Some facilities "are hesitant to
relinquish control" of medication management due to fear that residents
do not have the "capacity to manage what are often complex medication
regimens." 2 98 Additionally, having an illegal substance on the property
2
may still place the facilities' Medicare or Medicaid funding at risk. 9
Thus, while self-administration is an effective way for residents in
nursing homes and assisted living facilities to obtain access to medical
marijuana, it still places the facilities, and potentially the residents'
safety, in jeopardy.300
Moreover, medical marijuana has the potential to be a viable
treatment option for many elderly Americans. 301 Providing access to
marijuana in nursing homes and other skilled nursing facilities could
bring relief to many residents. 302 Therefore, there is currently the need
for a solution that permits elderly residents to overcome the barriers
surrounding access to medical marijuana in order to begin receiving
much needed treatment.303

PharmacyServices, supranote 237, at 3.
294. See Palace & Reingold, supranote 243, at 95, 97 (explaining the policy of a nursing home
that allows patients to utilize medical marijuana so long as they can self-administer the marijuana or
can utilize the marijuana with the assistance of a personal "caregiver who is not a staff member");
Parker, supra note 283 (mentioning a nursing home that allows patients to self-administer medical
marijuana but only in their own room); Fanning, supra note 61.
295. Palace & Reingold, supranote 243, at 97.
296. See Cope & Goldman, supra note 240, at 12 (discussing the harm that can come of
self-administration of medications amongst elderly residents residing in assisted living facilities).
297. See id. (explaining that some residents of assisted living facilities lose their ability to
self-administer their medications due to cognitive or physical decline over time).
298. Id.
299. See Parker, supra note 283 (noting that having a nursing home provider does not permit
medical marijuana in their facilities because such facilities would like to maintain compliance with
the federal Medicare program).
300. See supra text accompanying notes 280-99.
301. See supra Part III.A.
302. See supra Part II.A.
303. See infra PartIV.
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309

CREATING AN EXEMPTION TO THE CSA

Currently, the CSA classifies marijuana as a Schedule I substance,
regardless of whether or not it is used for medical purposes. 304 There
have been several attempts made to legalize or reschedule marijuana so
that it is no longer categorized as a Schedule I substance.305 Thus far,
these attempts have been in vain.06 As such, simply suggesting that
medical marijuana should be legalized by the states will not create the
result needed to provide relief to patients residing in nursing homes and
other skilled nursing facilities."'
Due to the confusion created by the differing attitudes of the
executive, legislative, and judicial branches toward the legalization of
medical marijuana, it should be up to Congress to provide clarity to the
American public. 308 In order to help care for the aging population of the
United States in a more compassionate way, this Note suggests that
Congress should create an exemption to marijuana's classification as a
Schedule I substance under the CSA. 309 This exemption should
specifically allow medical marijuana to be utilized by residents of
nursing homes, assisted living facilities, and other residential skilled
nursing facilities in states where medical marijuana is currently legal." 0
A.

Medical MarijuanaShould Be Legalizedfor NursingHome
Residents

Even with thirty-three states legalizing medical marijuana,311 the
federal prohibition on marijuana limits the number of people who have
access to it.3 12 Marijuana's designation as a Schedule I substance
imposes several barriers that make it difficult for people to obtain
medical marijuana."3 These barriers are amplified for senior citizens
who suffer from many of the conditions that medical marijuana may
help to alleviate.31 4 While there are some ways in which residents in
nursing homes and assisted living communities are able to obtain
medical marijuana, as it stands today, facilities that permit its use are
jeopardizing their federal funding and subjecting themselves to potential
304.

See supra Part I.B.

305.

See supra Part II.B.2-3.

306.
307.
308.
309.
310.
311.

See supra Part II.B.2.
See supra Part III.A-B.
See supra Part III; Fanning, supra note 61.
See infra Part IV.B.
See infra Part IV.B.
See supra note 174 and accompanying text.

312.

See supra Part III.

313. See supra Part III.B.
314. See supra Part III.A.
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criminal liability.3 " Thus, if Congress were to allow this population to
legally utilize medical marijuana, both nursing home providers and
3 16
nursing home residents would benefit.
B.

Legislation Should Be Enacted to Legalize Medical Marijuana Use
in Nursing Homes

To ensure that residents of nursing homes, assisted living facilities,
and other skilled nursing facilities have access to medical marijuana,
Congress should pass legislation that carves an exception in the current
CSA. 317 This legislation would permit nursing homes, and certain other
facilities in states that have legalized medical marijuana, to permit their
318
residents to utilize medical marijuana. This legislation could state:
Section 1. Short Title.
This Act may be cited as the "Medical Marijuana for Nursing Home
3 19
Residents Act."
Section 2. Protection for Nursing Home Resident Participation in
State-Approved Marijuana Programs. 320
(a) Protection of Patients - Notwithstanding any other provision of
law, the Attorney General of the United States shall not arrest,
prosecute, or penalize any individual residing in a nursing home,
assisted living facility, or other skilled nursing facility, under the laws
administered by the Department of Justice by reason of the resident
321
participating in a State-approved medical marijuana program.
(b) Protection of Caregivers and Physicians - Notwithstanding any
other provision of law, the Attorney General of the United States shall
not arrest, prosecute, or penalize any prescribing physician, or
designated caregiver, of an individual residing in a facility, including
staff of physicians' offices, nursing homes, assisted living facilities, or
other skilled nursing facilities, under the laws administered by the
Department of Justice by reason of the caregiver or physician
facilitating the resident's participation in a state-approved medical
3 22

marijuana program.
(c) Protection of Facilities - Notwithstanding any other provision of
315.
316.

See supra notes 280-89 and accompanying text.
See supra Part III.

317.

See Parker, supra note 283 ("Until more clarity comes from the federal level on the matter

[of medical marijuana use in nursing homes] . . .most organizations will base policy on their use of
Medicare and Medicaid funding.").
318. See infra notes 319-28 and accompanying text.
319. See Veterans Cannabis Use for Safe Healing Act, H.R. 2191, 116th Cong. (2019).
320. See id.
321. See id.
322. See id.; FLA. CONST. art. X, § 29; N.Y. COMP. CODES R. & REGS. tit. 10, § 1004.23 (2018)
(allowing staff of nursing homes and other facilities to have the protections of a designated
caregiver).
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law, the Attorney General of the United States shall not prosecute or
penalize any nursing home, assisted living facility, or other skilled
nursing facility, under the laws administered by the Department of
Justice by reason of permitting qualifying patients to participate in a
state-approved medical marijuana program. 323
(d) Provision of Benefits - No such resident, facility, or physician,
shall be denied any benefit under the laws administered by the federal
government by reason of the physician, resident, or facility
participating in a state-approved marijuana program. 324
(e) Definitions. - In this section:
(1) The term "marijuana" has the meaning given the term
"marihuana" in Section 102 of the Controlled Substances Act (21

U.S.C. 802).325
(2) The term "State" has the meaning given that term in Section

101 of title 38, United States Code. 326
(3) The term "caregiver" shall have the meaning given to the
term in the qualifying state's medical marijuana statute but shall also
include the term as defined in Section (e)(4) of this statute. 327
(4) A "caregiver" shall be either a natural person or a facility. 328
For purpose of this section, a "facility" shall mean: residential health
care facility, nursing home, assisted living community or facility,
skilled nursing facility, or its designated staff members. 329
(5) The term "benefit" shall refer to federally funded programs
for eligible physicians, patients, or facilities, such as Department of
Veterans Affairs benefits, Medicare, or Medicaid.3 3 0

By providing that both the resident and facility must be in
compliance with state law, the state retains control over monitoring
medical marijuana laws. 31 This proposed legislation also ensures that
most states will not have to change their laws in order to be in
compliance with the statute. 33 2 If a state were to decide that they do not
want to legalize medical marijuana, nothing in the proposed statute
mandates legalization. 333
See H.R. 2191; tit. 10, § 1004.23.
See H.R.2191.
Id.
Id.
327. See id.; FLA. STAT. ANN. § 381.986 (West 2014) (providing an example of a state's
definition of "caregiver"); tit. 10, § 1004.23 (providing that facilities may be caregivers).
328. Tit. 10, § 1004.3(k).
329. See id.
330. See H.R. 2191.
323.
324.
325.
326.

331. See supra text accompanying notes 16-20 (explaining the current clash between federal
and state law).
332. See supra text accompanying notes 318-29 (relying on states to first enact medical

marijuana legislation).
333. See supra text accompanying notes 318-29.
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This phrasing would also ensure that only nursing home residents
with a serious, qualifying health condition have access to medical
marijuana, as the residents would still have to be in compliance with
state law. 334 It would not openly allow the use of medical marijuana by
3
any nursing home or assisted living facility resident. " Ultimately, this
legislation would create a shift in policy and would offer a new
treatment option for a subset of seniors who are currently unable to
36
access medical marijuana.3 The end result: more compassionate care
7
for our aging population."
V.

CONCLUSION

Medical marijuana has become a dividing force between the federal
and state governments. 338 Nursing homes and skilled nursing facilities
have a duty to accommodate and care for their patients, but federal law
prohibits them from fulfilling this duty by restricting patients' access to
medical marijuana treatment.339 In making an exception to marijuana's
current classification as a Schedule I substance, the federal government
has the opportunity to relieve the suffering of our elderly population who
3
live each day with debilitating illnesses. 40 Though the federal
government does not appear to be ready to completely reschedule
34 1
there should be an
marijuana in order to legalize it on a federal level,
exception made to allow for the use of medical marijuana in nursing
342
homes and other skilled nursing facilities.
Over the past several decades, public opinion has shifted to support
the use of medical marijuana to aid in the treatment of debilitating health
conditions.34 3 It is now up to Congress to represent its constituents and
take bipartisan action in addressing the issue of medical marijuana.344
345
The proposed Medical Marijuana for Nursing Home Residents Act
would both permit nursing homes to fulfill their duty to their patients
334. See supra text accompanying note 320.
335. See supra text accompanying notes 320-23 (stipulating that this proposed legislation only
protects patients and facilities participating in state-approved medical marijuana programs).
336. See supra Parts III, IV.A.
337. See supra Part III.B.
338. See supra Part II.
339. See Lax & Wisner, supra note 282, at 11. But see Assenberg v. Anacortes Hous. Auth.,
268 F. App'x 643, 644 (9th Cir. 2008) (holding that the government does not have to accommodate
illegal drug use).
340.
341.

See supra Part III.A.
See supra Part II.B.

342.

See supra Part IV.

343. See Groundbreaking, Comprehensive,
Medical Marijuana, supra note 172.

Vital:

The National Nursing Guidelines for

344. See Fanning, supra note 61.
345. See supra text accompanying note 319.
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and aid in the treatment of ill seniors. 3 " Ultimately, this type of
legislation would allow Congress to help alleviate the pain and suffering
of patients, like Joy Seligman, who simply want relief from their
reliance on narcotics, and more so, from their pain.34 7
Katelyn Vaiana*

346. See supra text accompanying notes 318-29.
347. See Seidman, supra note 1.
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